Skip to main content
PMC home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1996 Sep;60(3):539–574. doi: 10.1128/mr.60.3.539-574.1996

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

J R Govan 1, V Deretic 1
PMCID: PMC239456  PMID: 8840786

Abstract

Respiratory infections with Pseudomonas aeruginosa and Burkholderia cepacia play a major role in the pathogenesis of cystic fibrosis (CF). This review summarizes the latest advances in understanding host-pathogen interactions in CF with an emphasis on the role and control of conversion to mucoidy in P. aeruginosa, a phenomenon epitomizing the adaptation of this opportunistic pathogen to the chronic chourse of infection in CF, and on the innate resistance to antibiotics of B. cepacia, person-to-person spread, and sometimes rapidly fatal disease caused by this organism. While understanding the mechanism of conversion to mucoidy in P. aeruginosa has progressed to the point where this phenomenon has evolved into a model system for studying bacterial stress response in microbial pathogenesis, the more recent challenge with B. cepacia, which has emerged as a potent bona fide CF pathogen, is discussed in the context of clinical issues, taxonomy, transmission, and potential modes of pathogenicity.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnarsson U., Glass S., Govan J. R. Fecal isolation of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol. 1989 Jan;27(1):96–98. doi: 10.1128/jcm.27.1.96-98.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allison D. G., Goldsbrough M. J. Polysaccharide production in Pseudomonas cepacia. J Basic Microbiol. 1994;34(1):3–10. doi: 10.1002/jobm.3620340102. [DOI] [PubMed] [Google Scholar]
  3. Ames P., DesJardins D., Pier G. B. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide. Infect Immun. 1985 Aug;49(2):281–285. doi: 10.1128/iai.49.2.281-285.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anastassiou E. D., Mintzas A. C., Kounavis C., Dimitracopoulos G. Alginate production by clinical nonmucoid Pseudomonas aeruginosa strains. J Clin Microbiol. 1987 Apr;25(4):656–659. doi: 10.1128/jcm.25.4.656-659.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anwar H., Brown M. R., Lambert P. A. Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytosis and serum bactericidal activity at different temperatures. J Gen Microbiol. 1983 Jul;129(7):2021–2027. doi: 10.1099/00221287-129-7-2021. [DOI] [PubMed] [Google Scholar]
  6. Anwar H., Strap J. L., Costerton J. W. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother. 1992 Jul;36(7):1347–1351. doi: 10.1128/aac.36.7.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Armstrong D. S., Grimwood K., Carzino R., Carlin J. B., Olinsky A., Phelan P. D. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ. 1995 Jun 17;310(6994):1571–1572. doi: 10.1136/bmj.310.6994.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Aronoff S. C., Quinn F. J., Jr, Stern R. C. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis. Pediatr Pulmonol. 1991;11(4):289–293. doi: 10.1002/ppul.1950110404. [DOI] [PubMed] [Google Scholar]
  9. BULLOCK G. L. CHARACTERISTICS AND PATHOGENICITY OF A CAPSULATED PSEUDOMONAS ISOLATED FROM GOLDFISH. Appl Microbiol. 1965 Jan;13:89–92. doi: 10.1128/am.13.1.89-92.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Baker N. R., Svanborg-Edén C. Role of alginate in the adherence of Pseudomonas aeruginosa. Antibiot Chemother (1971) 1989;42:72–79. doi: 10.1159/000417607. [DOI] [PubMed] [Google Scholar]
  11. Baltimore R. S., Mitchell M. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains. J Infect Dis. 1980 Feb;141(2):238–247. doi: 10.1093/infdis/141.2.238. [DOI] [PubMed] [Google Scholar]
  12. Baltimore R. S., Shedd D. G. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa. Pediatr Res. 1983 Dec;17(12):952–958. doi: 10.1203/00006450-198312000-00006. [DOI] [PubMed] [Google Scholar]
  13. Barasch J., Kiss B., Prince A., Saiman L., Gruenert D., al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature. 1991 Jul 4;352(6330):70–73. doi: 10.1038/352070a0. [DOI] [PubMed] [Google Scholar]
  14. Barton A. D., Ryder K., Lourenço R. V., Dralle W., Weiss S. G. Inflammatory reaction and airway damage in cystic fibrosis. J Lab Clin Med. 1976 Sep;88(3):423–426. [PubMed] [Google Scholar]
  15. Bayer A. S., Eftekhar F., Tu J., Nast C. C., Speert D. P. Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa. Infect Immun. 1990 May;58(5):1344–1349. doi: 10.1128/iai.58.5.1344-1349.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bayer A. S., Speert D. P., Park S., Tu J., Witt M., Nast C. C., Norman D. C. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Infect Immun. 1991 Jan;59(1):302–308. doi: 10.1128/iai.59.1.302-308.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Beckman W., Lessie T. G. Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source. J Bacteriol. 1979 Dec;140(3):1126–1128. doi: 10.1128/jb.140.3.1126-1128.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bender J. G., Florman A. L., Van Epps D. E. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation. Pediatr Res. 1987 Oct;22(4):383–388. doi: 10.1203/00006450-198710000-00002. [DOI] [PubMed] [Google Scholar]
  19. Benson A. K., Haldenwang W. G. Bacillus subtilis sigma B is regulated by a binding protein (RsbW) that blocks its association with core RNA polymerase. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2330–2334. doi: 10.1073/pnas.90.6.2330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Berry A., DeVault J. D., Chakrabarty A. M. High osmolarity is a signal for enhanced algD transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains. J Bacteriol. 1989 May;171(5):2312–2317. doi: 10.1128/jb.171.5.2312-2317.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Bevivino A., Tabacchioni S., Chiarini L., Carusi M. V., Del Gallo M., Visca P. Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia cepacia. Microbiology. 1994 May;140(Pt 5):1069–1077. doi: 10.1099/13500872-140-5-1069. [DOI] [PubMed] [Google Scholar]
  22. Birrer P., McElvaney N. G., Rüdeberg A., Sommer C. W., Liechti-Gallati S., Kraemer R., Hubbard R., Crystal R. G. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med. 1994 Jul;150(1):207–213. doi: 10.1164/ajrccm.150.1.7912987. [DOI] [PubMed] [Google Scholar]
  23. Bottone E. J., Douglas S. D., Rausen A. R., Keusch G. T. Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol. 1975 May;1(5):425–428. doi: 10.1128/jcm.1.5.425-428.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Boucher J. C., Martinez-Salazar J., Schurr M. J., Mudd M. H., Yu H., Deretic V. Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J Bacteriol. 1996 Jan;178(2):511–523. doi: 10.1128/jb.178.2.511-523.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Boyd A., Chakrabarty A. M. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol. 1994 Jul;60(7):2355–2359. doi: 10.1128/aem.60.7.2355-2359.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Boyd A., Ghosh M., May T. B., Shinabarger D., Keogh R., Chakrabarty A. M. Sequence of the algL gene of Pseudomonas aeruginosa and purification of its alginate lyase product. Gene. 1993 Sep 6;131(1):1–8. doi: 10.1016/0378-1119(93)90662-m. [DOI] [PubMed] [Google Scholar]
  27. Brown K. L., Hughes K. T. The role of anti-sigma factors in gene regulation. Mol Microbiol. 1995 May;16(3):397–404. doi: 10.1111/j.1365-2958.1995.tb02405.x. [DOI] [PubMed] [Google Scholar]
  28. Brown M. A., Morgan W. J., Finley P. R., Scuderi P. Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis. Pediatr Pulmonol. 1991;10(2):86–91. doi: 10.1002/ppul.1950100209. [DOI] [PubMed] [Google Scholar]
  29. Bukau B. Regulation of the Escherichia coli heat-shock response. Mol Microbiol. 1993 Aug;9(4):671–680. doi: 10.1111/j.1365-2958.1993.tb01727.x. [DOI] [PubMed] [Google Scholar]
  30. Burdge D. R., Nakielna E. M., Noble M. A. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol. 1993 Mar;14(3):127–130. doi: 10.1086/646697. [DOI] [PubMed] [Google Scholar]
  31. Burnie J. P., al-Wardi E. J., Williamson P., Matthews R. C., Webb K., David T. Defining potential targets for immunotherapy in Burkholderia cepacia infection. FEMS Immunol Med Microbiol. 1995 Jan;10(2):157–164. doi: 10.1111/j.1574-695X.1995.tb00026.x. [DOI] [PubMed] [Google Scholar]
  32. Burns M. W., May J. R. Bacterial precipitins in serum of patients with cystic fibrosis. Lancet. 1968 Feb 10;1(7537):270–272. doi: 10.1016/s0140-6736(68)90121-9. [DOI] [PubMed] [Google Scholar]
  33. Butler S. L., Doherty C. J., Hughes J. E., Nelson J. W., Govan J. R. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol. 1995 Apr;33(4):1001–1004. doi: 10.1128/jcm.33.4.1001-1004.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Butler S. L., Nelson J. W., Poxton I. R., Govan J. R. Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis. FEMS Immunol Med Microbiol. 1994 May;8(4):285–292. doi: 10.1111/j.1574-695X.1994.tb00454.x. [DOI] [PubMed] [Google Scholar]
  35. Bye M. R., Ewig J. M., Quittell L. M. Cystic fibrosis. Lung. 1994;172(5):251–270. doi: 10.1007/BF00164308. [DOI] [PubMed] [Google Scholar]
  36. Bédard M., McClure C. D., Schiller N. L., Francoeur C., Cantin A., Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir Cell Mol Biol. 1993 Oct;9(4):455–462. doi: 10.1165/ajrcmb/9.4.455. [DOI] [PubMed] [Google Scholar]
  37. CETIN E. T., TOERECI K., ANG O. ENCAPSULATED PSEUDOMONAS AERUGINOSA (PSEUDOMONAS AERUGINOSA MUCOSUS) STRAINS. J Bacteriol. 1965 May;89:1432–1433. doi: 10.1128/jb.89.5.1432-1433.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Cabral D. A., Loh B. A., Speert D. P. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Pediatr Res. 1987 Oct;22(4):429–431. doi: 10.1203/00006450-198710000-00013. [DOI] [PubMed] [Google Scholar]
  39. Cameron R. M., Stevenson K., Inglis N. F., Klausen J., Sharp J. M. Identification and characterization of a putative serine protease expressed in vivo by Mycobacterium avium subsp. paratuberculosis. Microbiology. 1994 Aug;140(Pt 8):1977–1982. doi: 10.1099/13500872-140-8-1977. [DOI] [PubMed] [Google Scholar]
  40. Caplen N. J., Alton E. W., Middleton P. G., Dorin J. R., Stevenson B. J., Gao X., Durham S. R., Jeffery P. K., Hodson M. E., Coutelle C. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med. 1995 Jan;1(1):39–46. doi: 10.1038/nm0195-39. [DOI] [PubMed] [Google Scholar]
  41. Carson L. A., Favero M. S., Bond W. W., Petersen N. J. Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water. Appl Microbiol. 1973 Mar;25(3):476–483. doi: 10.1128/am.25.3.476-483.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ceri H., McArthur H. A., Whitfield C. Association of alginate from Pseudomonas aeruginosa with two forms of heparin-binding lectin isolated from rat lung. Infect Immun. 1986 Jan;51(1):1–5. doi: 10.1128/iai.51.1.1-5.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Cheng H. P., Lessie T. G. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol. 1994 Jul;176(13):4034–4042. doi: 10.1128/jb.176.13.4034-4042.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Chi E., Bartlett D. H. An rpoE-like locus controls outer membrane protein synthesis and growth at cold temperatures and high pressures in the deep-sea bacterium Photobacterium sp. strain SS9. Mol Microbiol. 1995 Aug;17(4):713–726. doi: 10.1111/j.1365-2958.1995.mmi_17040713.x. [DOI] [PubMed] [Google Scholar]
  45. Chitnis C. E., Ohman D. E. Cloning of Pseudomonas aeruginosa algG, which controls alginate structure. J Bacteriol. 1990 Jun;172(6):2894–2900. doi: 10.1128/jb.172.6.2894-2900.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Chitnis C. E., Ohman D. E. Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure. Mol Microbiol. 1993 May;8(3):583–593. doi: 10.1111/j.1365-2958.1993.tb01602.x. [DOI] [PubMed] [Google Scholar]
  47. Christenson J. C., Welch D. F., Mukwaya G., Muszynski M. J., Weaver R. E., Brenner D. J. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol. 1989 Feb;27(2):270–273. doi: 10.1128/jcm.27.2.270-273.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Chu L., May T. B., Chakrabarty A. M., Misra T. K. Nucleotide sequence and expression of the algE gene involved in alginate biosynthesis by Pseudomonas aeruginosa. Gene. 1991 Oct 30;107(1):1–10. doi: 10.1016/0378-1119(91)90290-r. [DOI] [PubMed] [Google Scholar]
  49. Cimolai N., Trombley C. Insertional sequence primers for Bordetella pertussis diagnostic polymerase chain reaction differentiate strains of Pseudomonas cepacia. J Infect Dis. 1995 Jul;172(1):293–295. doi: 10.1093/infdis/172.1.293. [DOI] [PubMed] [Google Scholar]
  50. Corkill J. E., Deveney J., Pratt J., Shears P., Smyth A., Heaf D., Hart C. A. Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams. Pediatr Res. 1994 Mar;35(3):299–302. doi: 10.1203/00006450-199403000-00003. [DOI] [PubMed] [Google Scholar]
  51. Costerton J. W., Cheng K. J., Geesey G. G., Ladd T. I., Nickel J. C., Dasgupta M., Marrie T. J. Bacterial biofilms in nature and disease. Annu Rev Microbiol. 1987;41:435–464. doi: 10.1146/annurev.mi.41.100187.002251. [DOI] [PubMed] [Google Scholar]
  52. Coyne M. J., Jr, Russell K. S., Coyle C. L., Goldberg J. B. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J Bacteriol. 1994 Jun;176(12):3500–3507. doi: 10.1128/jb.176.12.3500-3507.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Crystal R. G., McElvaney N. G., Rosenfeld M. A., Chu C. S., Mastrangeli A., Hay J. G., Brody S. L., Jaffe H. A., Eissa N. T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994 Sep;8(1):42–51. doi: 10.1038/ng0994-42. [DOI] [PubMed] [Google Scholar]
  54. DOGGETT R. G., HARRISON G. M., WALLIS E. S. COMPARISON OF SOME PROPERTIES OF PSEUDOMONAS AERUGINOSA ISOLATED FROM INFECTIONS IN PERSONS WITH AND WITHOUT CYSTIC FIBROSIS. J Bacteriol. 1964 Feb;87:427–431. doi: 10.1128/jb.87.2.427-431.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Dailey R. H., Benner E. J. Necrotizing pneumonicitis due to the pseudomonad "eugonic oxidizer--group I". N Engl J Med. 1968 Aug 15;279(7):361–362. doi: 10.1056/NEJM196808152790706. [DOI] [PubMed] [Google Scholar]
  56. Daley L., Pier G. B., Liporace J. D., Eardley D. D. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. J Immunol. 1985 May;134(5):3089–3093. [PubMed] [Google Scholar]
  57. Darzins A., Chakrabarty A. M. Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa. J Bacteriol. 1984 Jul;159(1):9–18. doi: 10.1128/jb.159.1.9-18.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Darzins A., Frantz B., Vanags R. I., Chakrabarty A. M. Nucleotide sequence analysis of the phosphomannose isomerase gene (pmi) of Pseudomonas aeruginosa and comparison with the corresponding Escherichia coli gene manA. Gene. 1986;42(3):293–302. doi: 10.1016/0378-1119(86)90233-7. [DOI] [PubMed] [Google Scholar]
  59. Darzins A., Nixon L. L., Vanags R. I., Chakrabarty A. M. Cloning of Escherichia coli and Pseudomonas aeruginosa phosphomannose isomerase genes and their expression in alginate-negative mutants of Pseudomonas aeruginosa. J Bacteriol. 1985 Jan;161(1):249–257. doi: 10.1128/jb.161.1.249-257.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Darzins A., Wang S. K., Vanags R. I., Chakrabarty A. M. Clustering of mutations affecting alginic acid biosynthesis in mucoid Pseudomonas aeruginosa. J Bacteriol. 1985 Nov;164(2):516–524. doi: 10.1128/jb.164.2.516-524.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Dasen S. E., LiPuma J. J., Kostman J. R., Stull T. L. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol. 1994 Oct;32(10):2422–2424. doi: 10.1128/jcm.32.10.2422-2424.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Davidson D. J., Dorin J. R., McLachlan G., Ranaldi V., Lamb D., Doherty C., Govan J., Porteous D. J. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet. 1995 Apr;9(4):351–357. doi: 10.1038/ng0495-351. [DOI] [PubMed] [Google Scholar]
  63. Davies D. G., Geesey G. G. Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl Environ Microbiol. 1995 Mar;61(3):860–867. doi: 10.1128/aem.61.3.860-867.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. DeVault J. D., Hendrickson W., Kato J., Chakrabarty A. M. Environmentally regulated algD promoter is responsive to the cAMP receptor protein in Escherichia coli. Mol Microbiol. 1991 Oct;5(10):2503–2509. doi: 10.1111/j.1365-2958.1991.tb02096.x. [DOI] [PubMed] [Google Scholar]
  65. DeVault J. D., Kimbara K., Chakrabarty A. M. Pulmonary dehydration and infection in cystic fibrosis: evidence that ethanol activates alginate gene expression and induction of mucoidy in Pseudomonas aeruginosa. Mol Microbiol. 1990 May;4(5):737–745. doi: 10.1111/j.1365-2958.1990.tb00644.x. [DOI] [PubMed] [Google Scholar]
  66. DeVries C. A., Ohman D. E. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation. J Bacteriol. 1994 Nov;176(21):6677–6687. doi: 10.1128/jb.176.21.6677-6687.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Deretic V., Dikshit R., Konyecsni W. M., Chakrabarty A. M., Misra T. K. The algR gene, which regulates mucoidy in Pseudomonas aeruginosa, belongs to a class of environmentally responsive genes. J Bacteriol. 1989 Mar;171(3):1278–1283. doi: 10.1128/jb.171.3.1278-1283.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Deretic V., Gill J. F., Chakrabarty A. M. Gene algD coding for GDPmannose dehydrogenase is transcriptionally activated in mucoid Pseudomonas aeruginosa. J Bacteriol. 1987 Jan;169(1):351–358. doi: 10.1128/jb.169.1.351-358.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Deretic V., Gill J. F., Chakrabarty A. M. Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene. Nucleic Acids Res. 1987 Jun 11;15(11):4567–4581. doi: 10.1093/nar/15.11.4567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Deretic V., Govan J. R., Konyecsni W. M., Martin D. W. Mucoid Pseudomonas aeruginosa in cystic fibrosis: mutations in the muc loci affect transcription of the algR and algD genes in response to environmental stimuli. Mol Microbiol. 1990 Feb;4(2):189–196. doi: 10.1111/j.1365-2958.1990.tb00586.x. [DOI] [PubMed] [Google Scholar]
  71. Deretic V., Hibler N. S., Holt S. C. Immunocytochemical analysis of AlgP (Hp1), a histonelike element participating in control of mucoidy in Pseudomonas aeruginosa. J Bacteriol. 1992 Feb;174(3):824–831. doi: 10.1128/jb.174.3.824-831.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Deretic V., Konyecsni W. M. Control of mucoidy in Pseudomonas aeruginosa: transcriptional regulation of algR and identification of the second regulatory gene, algQ. J Bacteriol. 1989 Jul;171(7):3680–3688. doi: 10.1128/jb.171.7.3680-3688.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Deretic V., Martin D. W., Schurr M. J., Mudd M. H., Hibler N. S., Curcic R., Boucher J. C. Conversion to mucoidy in Pseudomonas aeruginosa. Biotechnology (N Y) 1993 Oct;11(10):1133–1136. doi: 10.1038/nbt1093-1133. [DOI] [PubMed] [Google Scholar]
  74. Deretic V., Mohr C. D., Martin D. W. Mucoid Pseudomonas aeruginosa in cystic fibrosis: signal transduction and histone-like elements in the regulation of bacterial virulence. Mol Microbiol. 1991 Jul;5(7):1577–1583. doi: 10.1111/j.1365-2958.1991.tb01903.x. [DOI] [PubMed] [Google Scholar]
  75. Deretic V., Schurr M. J., Boucher J. C., Martin D. W. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J Bacteriol. 1994 May;176(10):2773–2780. doi: 10.1128/jb.176.10.2773-2780.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Deretic V., Schurr M. J., Yu H. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis. Trends Microbiol. 1995 Sep;3(9):351–356. doi: 10.1016/s0966-842x(00)88974-x. [DOI] [PubMed] [Google Scholar]
  77. Diaz E., Mosovich L. L., Neter E. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis. J Infect Dis. 1970 Mar;121(3):269–274. doi: 10.1093/infdis/121.3.269. [DOI] [PubMed] [Google Scholar]
  78. Doggett R. G. Incidence of mucoid Pseudomonas aeruginosa from clinical sources. Appl Microbiol. 1969 Nov;18(5):936–937. doi: 10.1128/am.18.5.936-937.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Doig P., Smith N. R., Todd T., Irvin R. T. Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells. Infect Immun. 1987 Jun;55(6):1517–1522. doi: 10.1128/iai.55.6.1517-1522.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Dorin J. R., Dickinson P., Alton E. W., Smith S. N., Geddes D. M., Stevenson B. J., Kimber W. L., Fleming S., Clarke A. R., Hooper M. L. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature. 1992 Sep 17;359(6392):211–215. doi: 10.1038/359211a0. [DOI] [PubMed] [Google Scholar]
  81. Dosanjh A., Lencer W., Brown D., Ausiello D. A., Stow J. L. Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates. Am J Physiol. 1994 Feb;266(2 Pt 1):C360–C366. doi: 10.1152/ajpcell.1994.266.2.C360. [DOI] [PubMed] [Google Scholar]
  82. Drumm M. L., Pope H. A., Cliff W. H., Rommens J. M., Marvin S. A., Tsui L. C., Collins F. S., Frizzell R. A., Wilson J. M. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell. 1990 Sep 21;62(6):1227–1233. doi: 10.1016/0092-8674(90)90398-x. [DOI] [PubMed] [Google Scholar]
  83. Dubnau E., Weir J., Nair G., Carter L., 3rd, Moran C., Jr, Smith I. Bacillus sporulation gene spo0H codes for sigma 30 (sigma H). J Bacteriol. 1988 Mar;170(3):1054–1062. doi: 10.1128/jb.170.3.1054-1062.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Duncan L., Losick R. SpoIIAB is an anti-sigma factor that binds to and inhibits transcription by regulatory protein sigma F from Bacillus subtilis. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2325–2329. doi: 10.1073/pnas.90.6.2325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Döring G., Bareth H., Gairing A., Wolz C., Botzenhart K. Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets. Epidemiol Infect. 1989 Dec;103(3):555–564. doi: 10.1017/s0950268800030958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Döring G. The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 2):S114–S117. doi: 10.1164/ajrccm/150.6_Pt_2.S114. [DOI] [PubMed] [Google Scholar]
  87. Ederer G. M., Matsen J. M. Colonization and infection with Pseudomonas cepacia. J Infect Dis. 1972 Jun;125(6):613–618. doi: 10.1093/infdis/125.6.613. [DOI] [PubMed] [Google Scholar]
  88. Elston H. R., Hoffman K. C. Increasing incidence of encapsulated Pseudomonas aeruginosa strains. Am J Clin Pathol. 1967 Nov;48(5):519–523. doi: 10.1093/ajcp/48.5_ts.519. [DOI] [PubMed] [Google Scholar]
  89. Elzer P. H., Phillips R. W., Kovach M. E., Peterson K. M., Roop R. M., 2nd Characterization and genetic complementation of a Brucella abortus high-temperature-requirement A (htrA) deletion mutant. Infect Immun. 1994 Oct;62(10):4135–4139. doi: 10.1128/iai.62.10.4135-4139.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Engelhardt J. F., Yankaskas J. R., Ernst S. A., Yang Y., Marino C. R., Boucher R. C., Cohn J. A., Wilson J. M. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet. 1992 Nov;2(3):240–248. doi: 10.1038/ng1192-240. [DOI] [PubMed] [Google Scholar]
  91. Erickson J. W., Gross C. A. Identification of the sigma E subunit of Escherichia coli RNA polymerase: a second alternate sigma factor involved in high-temperature gene expression. Genes Dev. 1989 Sep;3(9):1462–1471. doi: 10.1101/gad.3.9.1462. [DOI] [PubMed] [Google Scholar]
  92. Erickson J. W., Vaughn V., Walter W. A., Neidhardt F. C., Gross C. A. Regulation of the promoters and transcripts of rpoH, the Escherichia coli heat shock regulatory gene. Genes Dev. 1987 Jul;1(5):419–432. doi: 10.1101/gad.1.5.419. [DOI] [PubMed] [Google Scholar]
  93. Ertesvåg H., Høidal H. K., Hals I. K., Rian A., Doseth B., Valla S. A family of modular type mannuronan C-5-epimerase genes controls alginate structure in Azotobacter vinelandii. Mol Microbiol. 1995 May;16(4):719–731. doi: 10.1111/j.1365-2958.1995.tb02433.x. [DOI] [PubMed] [Google Scholar]
  94. Evans D. J., Pier G. B., Coyne M. J., Jr, Goldberg J. B. The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients. Mol Microbiol. 1994 Aug;13(3):427–434. doi: 10.1111/j.1365-2958.1994.tb00437.x. [DOI] [PubMed] [Google Scholar]
  95. Evans L. R., Linker A. Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J Bacteriol. 1973 Nov;116(2):915–924. doi: 10.1128/jb.116.2.915-924.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Fialho A. M., Zielinski N. A., Fett W. F., Chakrabarty A. M., Berry A. Distribution of alginate gene sequences in the Pseudomonas rRNA homology group I-Azomonas-Azotobacter lineage of superfamily B procaryotes. Appl Environ Microbiol. 1990 Feb;56(2):436–443. doi: 10.1128/aem.56.2.436-443.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Fisher M. C., LiPuma J. J., Dasen S. E., Caputo G. C., Mortensen J. E., McGowan K. L., Stull T. L. Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J Pediatr. 1993 Nov;123(5):745–747. doi: 10.1016/s0022-3476(05)80851-0. [DOI] [PubMed] [Google Scholar]
  98. FitzSimmons S. C. The changing epidemiology of cystic fibrosis. J Pediatr. 1993 Jan;122(1):1–9. doi: 10.1016/s0022-3476(05)83478-x. [DOI] [PubMed] [Google Scholar]
  99. Fleischmann R. D., Adams M. D., White O., Clayton R. A., Kirkness E. F., Kerlavage A. R., Bult C. J., Tomb J. F., Dougherty B. A., Merrick J. M. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496–512. doi: 10.1126/science.7542800. [DOI] [PubMed] [Google Scholar]
  100. Flynn J. L., Ohman D. E. Cloning of genes from mucoid Pseudomonas aeruginosa which control spontaneous conversion to the alginate production phenotype. J Bacteriol. 1988 Apr;170(4):1452–1460. doi: 10.1128/jb.170.4.1452-1460.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Flynn J. L., Ohman D. E. Use of a gene replacement cosmid vector for cloning alginate conversion genes from mucoid and nonmucoid Pseudomonas aeruginosa strains: algS controls expression of algT. J Bacteriol. 1988 Jul;170(7):3228–3236. doi: 10.1128/jb.170.7.3228-3236.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Folsom B. R., Chapman P. J., Pritchard P. H. Phenol and trichloroethylene degradation by Pseudomonas cepacia G4: kinetics and interactions between substrates. Appl Environ Microbiol. 1990 May;56(5):1279–1285. doi: 10.1128/aem.56.5.1279-1285.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Franklin M. J., Chitnis C. E., Gacesa P., Sonesson A., White D. C., Ohman D. E. Pseudomonas aeruginosa AlgG is a polymer level alginate C5-mannuronan epimerase. J Bacteriol. 1994 Apr;176(7):1821–1830. doi: 10.1128/jb.176.7.1821-1830.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Franklin M. J., Ohman D. E. Identification of algF in the alginate biosynthetic gene cluster of Pseudomonas aeruginosa which is required for alginate acetylation. J Bacteriol. 1993 Aug;175(16):5057–5065. doi: 10.1128/jb.175.16.5057-5065.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Franklin M. J., Ohman D. E. Identification of algI and algJ in the Pseudomonas aeruginosa alginate biosynthetic gene cluster which are required for alginate O acetylation. J Bacteriol. 1996 Apr;178(8):2186–2195. doi: 10.1128/jb.178.8.2186-2195.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Friend P. A., Newsom S. W. Hygiene for hydrotherapy pools. J Hosp Infect. 1986 Nov;8(3):213–216. doi: 10.1016/0195-6701(86)90115-5. [DOI] [PubMed] [Google Scholar]
  107. Fujiwara S., Zielinski N. A., Chakrabarty A. M. Enhancer-like activity of A1gR1-binding site in alginate gene activation: positional, orientational, and sequence specificity. J Bacteriol. 1993 Sep;175(17):5452–5459. doi: 10.1128/jb.175.17.5452-5459.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Fyfe J. A., Govan J. R. Alginate synthesis in mucoid Pseudomonas aeruginosa: a chromosomal locus involved in control. J Gen Microbiol. 1980 Aug;119(2):443–450. doi: 10.1099/00221287-119-2-443. [DOI] [PubMed] [Google Scholar]
  109. Fyfe J. A., Govan J. R. Chromosomal loci associated with antibiotic hypersensitivity in pulmonary isolates of Pseudomonas aeruginosa. J Gen Microbiol. 1984 Apr;130(4):825–834. doi: 10.1099/00221287-130-4-825. [DOI] [PubMed] [Google Scholar]
  110. Gabriel S. E., Brigman K. N., Koller B. H., Boucher R. C., Stutts M. J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science. 1994 Oct 7;266(5182):107–109. doi: 10.1126/science.7524148. [DOI] [PubMed] [Google Scholar]
  111. Garner C. V., DesJardins D., Pier G. B. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide. Infect Immun. 1990 Jun;58(6):1835–1842. doi: 10.1128/iai.58.6.1835-1842.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Gessner A. R., Mortensen J. E. Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol. 1990 Oct;33(2):115–120. doi: 10.1099/00222615-33-2-115. [DOI] [PubMed] [Google Scholar]
  113. Gill J. F., Deretic V., Chakrabarty A. M. Overproduction and assay of Pseudomonas aeruginosa phosphomannose isomerase. J Bacteriol. 1986 Aug;167(2):611–615. doi: 10.1128/jb.167.2.611-615.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Gilligan P. H., Gage P. A., Bradshaw L. M., Schidlow D. V., DeCicco B. T. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1985 Jul;22(1):5–8. doi: 10.1128/jcm.22.1.5-8.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Gilligan P. H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev. 1991 Jan;4(1):35–51. doi: 10.1128/cmr.4.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Gladman G., Connor P. J., Williams R. F., David T. J. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch Dis Child. 1992 Feb;67(2):192–195. doi: 10.1136/adc.67.2.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Glass S., Govan J. R. Pseudomonas cepacia--fatal pulmonary infection in a patient with cystic fibrosis. J Infect. 1986 Sep;13(2):157–158. doi: 10.1016/s0163-4453(86)92953-1. [DOI] [PubMed] [Google Scholar]
  118. Godard C., Plesiat P., Michel-Briand Y. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months. Eur J Med. 1993 Feb;2(2):117–120. [PubMed] [Google Scholar]
  119. Goldberg J. B., Coyne M. J., Jr, Neely A. N., Holder I. A. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect Immun. 1995 Oct;63(10):4166–4169. doi: 10.1128/iai.63.10.4166-4169.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Goldberg J. B., Dahnke T. Pseudomonas aeruginosa AlgB, which modulates the expression of alginate, is a member of the NtrC subclass of prokaryotic regulators. Mol Microbiol. 1992 Jan;6(1):59–66. doi: 10.1111/j.1365-2958.1992.tb00837.x. [DOI] [PubMed] [Google Scholar]
  121. Goldberg J. B., Gorman W. L., Flynn J. L., Ohman D. E. A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J Bacteriol. 1993 Mar;175(5):1303–1308. doi: 10.1128/jb.175.5.1303-1308.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Goldberg J. B., Hatano K., Meluleni G. S., Pier G. B. Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10716–10720. doi: 10.1073/pnas.89.22.10716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Goldberg J. B., Hatano K., Pier G. B. Synthesis of lipopolysaccharide O side chains by Pseudomonas aeruginosa PAO1 requires the enzyme phosphomannomutase. J Bacteriol. 1993 Mar;175(6):1605–1611. doi: 10.1128/jb.175.6.1605-1611.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Goldberg J. B., Ohman D. E. Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate. J Bacteriol. 1984 Jun;158(3):1115–1121. doi: 10.1128/jb.158.3.1115-1121.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Goldberg J. B., Ohman D. E. Construction and characterization of Pseudomonas aeruginosa algB mutants: role of algB in high-level production of alginate. J Bacteriol. 1987 Apr;169(4):1593–1602. doi: 10.1128/jb.169.4.1593-1602.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Goldmann D. A., Klinger J. D. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr. 1986 May;108(5 Pt 2):806–812. doi: 10.1016/s0022-3476(86)80749-1. [DOI] [PubMed] [Google Scholar]
  127. Goldstein R., Sun L., Jiang R. Z., Sajjan U., Forstner J. F., Campanelli C. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol. 1995 Feb;177(4):1039–1052. doi: 10.1128/jb.177.4.1039-1052.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Gonzalez C. F., Vidaver A. K. Bacteriocin, plasmid and pectolytic diversity in Pseudomonas cepacia of clinical and plant origin. J Gen Microbiol. 1979 Jan;110(1):161–170. doi: 10.1099/00221287-110-1-161. [DOI] [PubMed] [Google Scholar]
  129. Govan J. R., Brown P. H., Maddison J., Doherty C. J., Nelson J. W., Dodd M., Greening A. P., Webb A. K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. doi: 10.1016/0140-6736(93)91881-l. [DOI] [PubMed] [Google Scholar]
  130. Govan J. R. Burkholderia cepacia in cystic fibrosis. N Engl J Med. 1995 Mar 23;332(12):819–821. [PubMed] [Google Scholar]
  131. Govan J. R., Doherty C., Glass S. Rational parameters for antibiotic therapy in patients with cystic fibrosis. Infection. 1987 Jul-Aug;15(4):300–307. doi: 10.1007/BF01644142. [DOI] [PubMed] [Google Scholar]
  132. Govan J. R., Fyfe J. A., Jarman T. R. Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida and Pseudomonas mendocina. J Gen Microbiol. 1981 Jul;125(1):217–220. doi: 10.1099/00221287-125-1-217. [DOI] [PubMed] [Google Scholar]
  133. Govan J. R., Fyfe J. A., McMillan C. The instability of mucoid Pseudomonas aeruginosa: fluctuation test and improved stability of the mucoid form in shaken culture. J Gen Microbiol. 1979 Jan;110(1):229–232. doi: 10.1099/00221287-110-1-229. [DOI] [PubMed] [Google Scholar]
  134. Govan J. R., Fyfe J. A. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J Antimicrob Chemother. 1978 May;4(3):233–240. doi: 10.1093/jac/4.3.233. [DOI] [PubMed] [Google Scholar]
  135. Govan J. R., Harris G. S. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol Sci. 1986 Oct;3(10):302–308. [PubMed] [Google Scholar]
  136. Govan J. R., Harris G. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J Clin Microbiol. 1985 Oct;22(4):490–494. doi: 10.1128/jcm.22.4.490-494.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Govan J. R. Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production. J Med Microbiol. 1975 Nov;8(4):513–522. doi: 10.1099/00222615-8-4-513. [DOI] [PubMed] [Google Scholar]
  138. Govan J. R., Nelson J. W. Microbiology of cystic fibrosis lung infections: themes and issues. J R Soc Med. 1993;86 (Suppl 20):11–18. [PMC free article] [PubMed] [Google Scholar]
  139. Govan J. R., Nelson J. W. Microbiology of lung infection in cystic fibrosis. Br Med Bull. 1992 Oct;48(4):912–930. doi: 10.1093/oxfordjournals.bmb.a072585. [DOI] [PubMed] [Google Scholar]
  140. Grothues D., Koopmann U., von der Hardt H., Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol. 1988 Oct;26(10):1973–1977. doi: 10.1128/jcm.26.10.1973-1977.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Guggino S. E. Gates of Janus: cystic fibrosis and diarrhea. Trends Microbiol. 1994 Mar;2(3):91–94. doi: 10.1016/0966-842x(94)90541-x. [DOI] [PubMed] [Google Scholar]
  142. HUANG N. N., VAN LOON E. L., SHENG K. T. The flora of the respiratory tract of patients with cystic fibrosis of the pancreas. J Pediatr. 1961 Oct;59:512–521. doi: 10.1016/s0022-3476(61)80234-5. [DOI] [PubMed] [Google Scholar]
  143. Haldenwang W. G. The sigma factors of Bacillus subtilis. Microbiol Rev. 1995 Mar;59(1):1–30. doi: 10.1128/mr.59.1.1-30.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Hancock R. E., Mutharia L. M., Chan L., Darveau R. P., Speert D. P., Pier G. B. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun. 1983 Oct;42(1):170–177. doi: 10.1128/iai.42.1.170-177.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Hatano K., Goldberg J. B., Pier G. B. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect Immun. 1995 Jan;63(1):21–26. doi: 10.1128/iai.63.1.21-26.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Hatano K., Goldberg J. B., Pier G. B. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule. J Bacteriol. 1993 Aug;175(16):5117–5128. doi: 10.1128/jb.175.16.5117-5128.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Hearst J. E., Elliott K. E. Identifying the killer in cystic fibrosis. Nat Med. 1995 Jul;1(7):626–627. doi: 10.1038/nm0795-626. [DOI] [PubMed] [Google Scholar]
  148. Heidt A., Monteil H., Richard C. O and H serotyping of Pseudomonas cepacia. J Clin Microbiol. 1983 Sep;18(3):738–740. doi: 10.1128/jcm.18.3.738-740.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Henry R. L., Dorman D. C., Brown J., Mellis C. Mucoid Pseudomonas aeruginosa in cystic fibrosis. Aust Paediatr J. 1982 Mar;18(1):43–45. doi: 10.1111/j.1440-1754.1982.tb01979.x. [DOI] [PubMed] [Google Scholar]
  150. Hershberger C. D., Ye R. W., Parsek M. R., Xie Z. D., Chakrabarty A. M. The algT (algU) gene of Pseudomonas aeruginosa, a key regulator involved in alginate biosynthesis, encodes an alternative sigma factor (sigma E). Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7941–7945. doi: 10.1073/pnas.92.17.7941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Hiratsu K., Amemura M., Nashimoto H., Shinagawa H., Makino K. The rpoE gene of Escherichia coli, which encodes sigma E, is essential for bacterial growth at high temperature. J Bacteriol. 1995 May;177(10):2918–2922. doi: 10.1128/jb.177.10.2918-2922.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Hoiby N., Flensborg E. W., Beck B., Friis B., Jacobsen S. V., Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis. 1977 Apr;58(2):65–79. [PubMed] [Google Scholar]
  153. Hoiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand Suppl. 1977;(262):1–96. [PubMed] [Google Scholar]
  154. Holmes B. The identification of Pseudomonas cepacia and its occurrence in clinical material. J Appl Bacteriol. 1986 Oct;61(4):299–314. doi: 10.1111/j.1365-2672.1986.tb04291.x. [DOI] [PubMed] [Google Scholar]
  155. Hughes K. T., Gillen K. L., Semon M. J., Karlinsey J. E. Sensing structural intermediates in bacterial flagellar assembly by export of a negative regulator. Science. 1993 Nov 19;262(5137):1277–1280. doi: 10.1126/science.8235660. [DOI] [PubMed] [Google Scholar]
  156. Høiby N., Döring G., Schiøtz P. O. The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol. 1986;40:29–53. doi: 10.1146/annurev.mi.40.100186.000333. [DOI] [PubMed] [Google Scholar]
  157. IACOCCA V. F., SIBINGA M., BARBERO G. J. RESPIRATORY TRACT BACTERIOLOGY IN CYSTIC FIBROSIS. Am J Dis Child. 1963 Sep;106:315–324. doi: 10.1001/archpedi.1963.02080050317012. [DOI] [PubMed] [Google Scholar]
  158. Imundo L., Barasch J., Prince A., Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3019–3023. doi: 10.1073/pnas.92.7.3019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Ishimoto K. S., Lory S. Formation of pilin in Pseudomonas aeruginosa requires the alternative sigma factor (RpoN) of RNA polymerase. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1954–1957. doi: 10.1073/pnas.86.6.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  161. Jarvis W. R., Olson D., Tablan O., Martone W. J. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol. 1987 Sep;3(3):233–236. doi: 10.1007/BF00149729. [DOI] [PubMed] [Google Scholar]
  162. Jensen E. T., Kharazmi A., Lam K., Costerton J. W., Høiby N. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun. 1990 Jul;58(7):2383–2385. doi: 10.1128/iai.58.7.2383-2385.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Jin S., Ishimoto K., Lory S. Nucleotide sequence of the rpoN gene and characterization of two downstream open reading frames in Pseudomonas aeruginosa. J Bacteriol. 1994 Mar;176(5):1316–1322. doi: 10.1128/jb.176.5.1316-1322.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Johansen H. K., Cryz S. J., Jr, Høiby N. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A. APMIS. 1994 Jul;102(7):545–553. [PubMed] [Google Scholar]
  165. Johansen H. K., Espersen F., Cryz S. J., Jr, Hougen H. P., Fomsgaard A., Rygaard J., Høiby N. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Infect Immun. 1994 Aug;62(8):3146–3155. doi: 10.1128/iai.62.8.3146-3155.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Johansen H. K., Høiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax. 1992 Feb;47(2):109–111. doi: 10.1136/thx.47.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Johnson K., Charles I., Dougan G., Pickard D., O'Gaora P., Costa G., Ali T., Miller I., Hormaeche C. The role of a stress-response protein in Salmonella typhimurium virulence. Mol Microbiol. 1991 Feb;5(2):401–407. doi: 10.1111/j.1365-2958.1991.tb02122.x. [DOI] [PubMed] [Google Scholar]
  168. Johnson W. M., Tyler S. D., Rozee K. R. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol. 1994 Apr;32(4):924–930. doi: 10.1128/jcm.32.4.924-930.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Joris B., Galleni M., Frère J. M., Labia R. Analysis of the penA gene of Pseudomonas cepacia 249. Antimicrob Agents Chemother. 1994 Feb;38(2):407–408. doi: 10.1128/aac.38.2.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Kanthakumar K., Cundell D. R., Johnson M., Wills P. J., Taylor G. W., Cole P. J., Wilson R. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br J Pharmacol. 1994 Jun;112(2):493–498. doi: 10.1111/j.1476-5381.1994.tb13100.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Kanthakumar K., Taylor G., Tsang K. W., Cundell D. R., Rutman A., Smith S., Jeffery P. K., Cole P. J., Wilson R. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun. 1993 Jul;61(7):2848–2853. doi: 10.1128/iai.61.7.2848-2853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Kapur V., Whittam T. S., Musser J. M. Is Mycobacterium tuberculosis 15,000 years old? J Infect Dis. 1994 Nov;170(5):1348–1349. doi: 10.1093/infdis/170.5.1348. [DOI] [PubMed] [Google Scholar]
  173. Karpati F., Malmborg A. S., Alfredsson H., Hjelte L., Strandvik B. Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population. Infection. 1994 Jul-Aug;22(4):258–263. doi: 10.1007/BF01739911. [DOI] [PubMed] [Google Scholar]
  174. Kato J., Chakrabarty A. M. Purification of the regulatory protein AlgR1 and its binding in the far upstream region of the algD promoter in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1760–1764. doi: 10.1073/pnas.88.5.1760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Kato J., Chu L., Kitano K., DeVault J. D., Kimbara K., Chakrabarty A. M., Misra T. K. Nucleotide sequence of a regulatory region controlling alginate synthesis in Pseudomonas aeruginosa: characterization of the algR2 gene. Gene. 1989 Dec 7;84(1):31–38. doi: 10.1016/0378-1119(89)90136-4. [DOI] [PubMed] [Google Scholar]
  176. Kato J., Misra T. K., Chakrabarty A. M. AlgR3, a protein resembling eukaryotic histone H1, regulates alginate synthesis in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2887–2891. doi: 10.1073/pnas.87.8.2887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Kelly N. M., Kluftinger J. L., Pasloske B. L., Paranchych W., Hancock R. E. Pseudomonas aeruginosa pili as ligands for nonopsonic phagocytosis by fibronectin-stimulated macrophages. Infect Immun. 1989 Dec;57(12):3841–3845. doi: 10.1128/iai.57.12.3841-3845.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  179. Kerem E., Corey M., Gold R., Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr. 1990 May;116(5):714–719. doi: 10.1016/s0022-3476(05)82653-8. [DOI] [PubMed] [Google Scholar]
  180. Kerr J. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J Infect. 1994 May;28(3):305–310. doi: 10.1016/s0163-4453(94)91943-7. [DOI] [PubMed] [Google Scholar]
  181. Kersulyte D., Struelens M. J., Deplano A., Berg D. E. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J Clin Microbiol. 1995 Aug;33(8):2216–2219. doi: 10.1128/jcm.33.8.2216-2219.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Khan T. Z., Wagener J. S., Bost T., Martinez J., Accurso F. J., Riches D. W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995 Apr;151(4):1075–1082. doi: 10.1164/ajrccm/151.4.1075. [DOI] [PubMed] [Google Scholar]
  183. Kharazmi A., Rechnitzer C., Schiøtz P. O., Jensen T., Baek L., Høiby N. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest. 1987 Jun;17(3):256–261. doi: 10.1111/j.1365-2362.1987.tb01245.x. [DOI] [PubMed] [Google Scholar]
  184. Kidambi S. P., Sundin G. W., Palmer D. A., Chakrabarty A. M., Bender C. L. Copper as a signal for alginate synthesis in Pseudomonas syringae pv. syringae. Appl Environ Microbiol. 1995 Jun;61(6):2172–2179. doi: 10.1128/aem.61.6.2172-2179.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Kilbourn J. P. Bacterial content and ionic composition of sputum in cystic fibrosis. Lancet. 1978 Feb 11;1(8059):334–334. doi: 10.1016/s0140-6736(78)90111-3. [DOI] [PubMed] [Google Scholar]
  186. Kiska D. L., Kerr A., Jones M. C., Caracciolo J. A., Eskridge B., Jordan M., Miller S., Hughes D., King N., Gilligan P. H. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol. 1996 Apr;34(4):886–891. doi: 10.1128/jcm.34.4.886-891.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Kluftinger J. L., Kelly N. M., Jost B. H., Hancock R. E. Fibronectin as an enhancer of nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages. Infect Immun. 1989 Sep;57(9):2782–2785. doi: 10.1128/iai.57.9.2782-2785.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Koch C., Høiby N. Pathogenesis of cystic fibrosis. Lancet. 1993 Apr 24;341(8852):1065–1069. doi: 10.1016/0140-6736(93)92422-p. [DOI] [PubMed] [Google Scholar]
  189. Komiyama K., Habbick B. F., Tumber S. K. Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Infect Immun. 1987 Oct;55(10):2364–2369. doi: 10.1128/iai.55.10.2364-2369.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Konyecsni W. M., Deretic V. DNA sequence and expression analysis of algP and algQ, components of the multigene system transcriptionally regulating mucoidy in Pseudomonas aeruginosa: algP contains multiple direct repeats. J Bacteriol. 1990 May;172(5):2511–2520. doi: 10.1128/jb.172.5.2511-2520.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Kostman J. R., Edlind T. D., LiPuma J. J., Stull T. L. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol. 1992 Aug;30(8):2084–2087. doi: 10.1128/jcm.30.8.2084-2087.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Krieg D. P., Bass J. A., Mattingly S. J. Aeration selects for mucoid phenotype of Pseudomonas aeruginosa. J Clin Microbiol. 1986 Dec;24(6):986–990. doi: 10.1128/jcm.24.6.986-990.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Krieg D. P., Bass J. A., Mattingly S. J. Phosphorylcholine stimulates capsule formation of phosphate-limited mucoid Pseudomonas aeruginosa. Infect Immun. 1988 Apr;56(4):864–873. doi: 10.1128/iai.56.4.864-873.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Krieg D. P., Helmke R. J., German V. F., Mangos J. A. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro. Infect Immun. 1988 Dec;56(12):3173–3179. doi: 10.1128/iai.56.12.3173-3179.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Krivan H. C., Ginsburg V., Roberts D. D. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). Arch Biochem Biophys. 1988 Jan;260(1):493–496. doi: 10.1016/0003-9861(88)90473-0. [DOI] [PubMed] [Google Scholar]
  196. Krivan H. C., Roberts D. D., Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6157–6161. doi: 10.1073/pnas.85.16.6157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Kronborg G., Hansen M. B., Svenson M., Fomsgaard A., Høiby N., Bendtzen K. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr Pulmonol. 1993 May;15(5):292–297. doi: 10.1002/ppul.1950150506. [DOI] [PubMed] [Google Scholar]
  198. Kubesch P., Dörk T., Wulbrand U., Kälin N., Neumann T., Wulf B., Geerlings H., Weissbrodt H., von der Hardt H., Tümmler B. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet. 1993 Jan 23;341(8839):189–193. doi: 10.1016/0140-6736(93)90062-l. [DOI] [PubMed] [Google Scholar]
  199. Kuehn M., Lent K., Haas J., Hagenzieker J., Cervin M., Smith A. L. Fimbriation of Pseudomonas cepacia. Infect Immun. 1992 May;60(5):2002–2007. doi: 10.1128/iai.60.5.2002-2007.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Kumon H., Tomochika K., Matunaga T., Ogawa M., Ohmori H. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol Immunol. 1994;38(8):615–619. doi: 10.1111/j.1348-0421.1994.tb01831.x. [DOI] [PubMed] [Google Scholar]
  201. LINKER A., JONES R. S. A POLYSACCHARIDE RESEMBLING ALGINIC ACID FROM A PSEUDOMONAS MICRO-ORGANISM. Nature. 1964 Oct 10;204:187–188. doi: 10.1038/204187a0. [DOI] [PubMed] [Google Scholar]
  202. Lacy D. E., Smith A. W., Stableforth D. E., Smith G., Weller P. H., Brown M. R. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 1995 Feb;10(3-4):253–261. doi: 10.1111/j.1574-695X.1995.tb00040.x. [DOI] [PubMed] [Google Scholar]
  203. Lacy D. E., Spencer D. A., Goldstein A., Weller P. H., Darbyshire P. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J Infect. 1993 Nov;27(3):301–304. doi: 10.1016/0163-4453(93)92271-w. [DOI] [PubMed] [Google Scholar]
  204. Lam J., Chan R., Lam K., Costerton J. W. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun. 1980 May;28(2):546–556. doi: 10.1128/iai.28.2.546-556.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Larsen G. Y., Stull T. L., Burns J. L. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol. 1993 Apr;31(4):788–792. doi: 10.1128/jcm.31.4.788-792.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Learn D. B., Brestel E. P., Seetharama S. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect Immun. 1987 Aug;55(8):1813–1818. doi: 10.1128/iai.55.8.1813-1818.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Lessie T. G., Phibbs P. V., Jr Alternative pathways of carbohydrate utilization in pseudomonads. Annu Rev Microbiol. 1984;38:359–388. doi: 10.1146/annurev.mi.38.100184.002043. [DOI] [PubMed] [Google Scholar]
  208. Lewin C., Doherty C., Govan J. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother. 1993 Jan;37(1):123–125. doi: 10.1128/aac.37.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. LiPuma J. J., Dasen S. E., Nielson D. W., Stern R. C., Stull T. L. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990 Nov 3;336(8723):1094–1096. doi: 10.1016/0140-6736(90)92571-x. [DOI] [PubMed] [Google Scholar]
  210. LiPuma J. J., Fisher M. C., Dasen S. E., Mortensen J. E., Stull T. L. Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis. 1991 Jul;164(1):133–136. doi: 10.1093/infdis/164.1.133. [DOI] [PubMed] [Google Scholar]
  211. LiPuma J. J., Stull T. L. Burkholderia cepacia in cystic fibrosis. N Engl J Med. 1995 Mar 23;332(12):820–821. [PubMed] [Google Scholar]
  212. Li X. Z., Livermore D. M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother. 1994 Aug;38(8):1732–1741. doi: 10.1128/aac.38.8.1732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Li X. Z., Ma D., Livermore D. M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob Agents Chemother. 1994 Aug;38(8):1742–1752. doi: 10.1128/aac.38.8.1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Lightfoot J., Lam J. S. Chromosomal mapping, expression and synthesis of lipopolysaccharide in Pseudomonas aeruginosa: a role for guanosine diphospho (GDP)-D-mannose. Mol Microbiol. 1993 May;8(4):771–782. doi: 10.1111/j.1365-2958.1993.tb01620.x. [DOI] [PubMed] [Google Scholar]
  215. Linker A., Jones R. S. A new polysaccharide resembling alginic acid isolated from pseudomonads. J Biol Chem. 1966 Aug 25;241(16):3845–3851. [PubMed] [Google Scholar]
  216. Lipinska B., Fayet O., Baird L., Georgopoulos C. Identification, characterization, and mapping of the Escherichia coli htrA gene, whose product is essential for bacterial growth only at elevated temperatures. J Bacteriol. 1989 Mar;171(3):1574–1584. doi: 10.1128/jb.171.3.1574-1584.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Lipinska B., Sharma S., Georgopoulos C. Sequence analysis and regulation of the htrA gene of Escherichia coli: a sigma 32-independent mechanism of heat-inducible transcription. Nucleic Acids Res. 1988 Nov 11;16(21):10053–10067. doi: 10.1093/nar/16.21.10053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Lipinska B., Zylicz M., Georgopoulos C. The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase. J Bacteriol. 1990 Apr;172(4):1791–1797. doi: 10.1128/jb.172.4.1791-1797.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Lipuma J. J., Marks-Austin K. A., Holsclaw D. S., Jr, Winnie G. B., Gilligan P. H., Stull T. L. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J. 1994 Aug;13(8):716–719. doi: 10.1097/00006454-199408000-00007. [DOI] [PubMed] [Google Scholar]
  220. Littlewood J. M., Miller M. G., Ghoneim A. T., Ramsden C. H. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet. 1985 Apr 13;1(8433):865–865. doi: 10.1016/s0140-6736(85)92222-6. [DOI] [PubMed] [Google Scholar]
  221. Lonetto M. A., Brown K. L., Rudd K. E., Buttner M. J. Analysis of the Streptomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial RNA polymerase sigma factors involved in the regulation of extracytoplasmic functions. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7573–7577. doi: 10.1073/pnas.91.16.7573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Lonetto M., Gribskov M., Gross C. A. The sigma 70 family: sequence conservation and evolutionary relationships. J Bacteriol. 1992 Jun;174(12):3843–3849. doi: 10.1128/jb.174.12.3843-3849.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Lonon M. K., Woods D. E., Straus D. C. Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol. 1988 May;26(5):979–984. doi: 10.1128/jcm.26.5.979-984.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Lynn A. R., Sokatch J. R. Incorporation of isotope from specifically labeled glucose into alginates of Pseudomonas aeruginosa and Azotobacter vinelandii. J Bacteriol. 1984 Jun;158(3):1161–1162. doi: 10.1128/jb.158.3.1161-1162.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. MacGeorge J., Korolik V., Morgan A. F., Asche V., Holloway B. W. Transfer of a chromosomal locus responsible for mucoid colony morphology in Pseudomonas aeruginosa isolated from cystic fibrosis patients to P. aeruginosa PAO. J Med Microbiol. 1986 Jun;21(4):331–336. doi: 10.1099/00222615-21-4-331. [DOI] [PubMed] [Google Scholar]
  226. Maharaj R., May T. B., Wang S. K., Chakrabarty A. M. Sequence of the alg8 and alg44 genes involved in the synthesis of alginate by Pseudomonas aeruginosa. Gene. 1993 Dec 22;136(1-2):267–269. doi: 10.1016/0378-1119(93)90477-k. [DOI] [PubMed] [Google Scholar]
  227. Mahenthiralingam E., Campbell M. E., Speert D. P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun. 1994 Feb;62(2):596–605. doi: 10.1128/iai.62.2.596-605.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Mai G. T., McCormack J. G., Seow W. K., Pier G. B., Jackson L. A., Thong Y. H. Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics. Infect Immun. 1993 Oct;61(10):4338–4343. doi: 10.1128/iai.61.10.4338-4343.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Mai G. T., Seow W. K., Pier G. B., McCormack J. G., Thong Y. H. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments. Infect Immun. 1993 Feb;61(2):559–564. doi: 10.1128/iai.61.2.559-564.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Marcus H., Baker N. R. Quantitation of adherence of mucoid and nonmucoid Pseudomonas aeruginosa to hamster tracheal epithelium. Infect Immun. 1985 Mar;47(3):723–729. doi: 10.1128/iai.47.3.723-729.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Marrie T. J., Harding G. K., Ronald A. R., Dikkema J., Lam J., Hoban S., Costerton J. W. Influence of mucoidy on antibody coating of Pseudomonas aeruginosa. J Infect Dis. 1979 Mar;139(3):357–361. doi: 10.1093/infdis/139.3.357. [DOI] [PubMed] [Google Scholar]
  232. Marshall E. Varmus orders up a review of the science of gene therapy. Science. 1995 Mar 17;267(5204):1588–1588. doi: 10.1126/science.7886441. [DOI] [PubMed] [Google Scholar]
  233. Martin C., Ichou M. A., Massicot P., Goudeau A., Quentin R. Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J Clin Microbiol. 1995 Jun;33(6):1461–1466. doi: 10.1128/jcm.33.6.1461-1466.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Martin D. W., Holloway B. W., Deretic V. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor. J Bacteriol. 1993 Feb;175(4):1153–1164. doi: 10.1128/jb.175.4.1153-1164.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Martin D. W., Schurr M. J., Mudd M. H., Deretic V. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol Microbiol. 1993 Aug;9(3):497–506. doi: 10.1111/j.1365-2958.1993.tb01711.x. [DOI] [PubMed] [Google Scholar]
  236. Martin D. W., Schurr M. J., Mudd M. H., Govan J. R., Holloway B. W., Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8377–8381. doi: 10.1073/pnas.90.18.8377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Martin D. W., Schurr M. J., Yu H., Deretic V. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response. J Bacteriol. 1994 Nov;176(21):6688–6696. doi: 10.1128/jb.176.21.6688-6696.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Martone W. J., Tablan O. C., Jarvis W. R. The epidemiology of nosocomial epidemic Pseudomonas cepacia infections. Eur J Epidemiol. 1987 Sep;3(3):222–232. doi: 10.1007/BF00149728. [DOI] [PubMed] [Google Scholar]
  239. Martínez-Salazar J. M., Moreno S., Nájera R., Boucher J. C., Espín G., Soberón-Chávez G., Deretic V. Characterization of the genes coding for the putative sigma factor AlgU and its regulators MucA, MucB, MucC, and MucD in Azotobacter vinelandii and evaluation of their roles in alginate biosynthesis. J Bacteriol. 1996 Apr;178(7):1800–1808. doi: 10.1128/jb.178.7.1800-1808.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. May T. B., Chakrabarty A. M. Pseudomonas aeruginosa: genes and enzymes of alginate synthesis. Trends Microbiol. 1994 May;2(5):151–157. doi: 10.1016/0966-842x(94)90664-5. [DOI] [PubMed] [Google Scholar]
  241. May T. B., Shinabarger D., Maharaj R., Kato J., Chu L., DeVault J. D., Roychoudhury S., Zielinski N. A., Berry A., Rothmel R. K. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev. 1991 Apr;4(2):191–206. doi: 10.1128/cmr.4.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. McAvoy M. J., Newton V., Paull A., Morgan J., Gacesa P., Russell N. J. Isolation of mucoid strains of Pseudomonas aeruginosa from non-cystic-fibrosis patients and characterisation of the structure of their secreted alginate. J Med Microbiol. 1989 Mar;28(3):183–189. doi: 10.1099/00222615-28-3-183. [DOI] [PubMed] [Google Scholar]
  243. McEachran D. W., Irvin R. T. Adhesion of Pseudomonas aeruginosa to human buccal epithelial cells: evidence for two classes of receptors. Can J Microbiol. 1985 Jun;31(6):563–569. doi: 10.1139/m85-105. [DOI] [PubMed] [Google Scholar]
  244. McGowan S. J., Gorham H. C., Hodgson D. A. Light-induced carotenogenesis in Myxococcus xanthus: DNA sequence analysis of the carR region. Mol Microbiol. 1993 Nov;10(4):713–735. doi: 10.1111/j.1365-2958.1993.tb00943.x. [DOI] [PubMed] [Google Scholar]
  245. McKevitt A. I., Bajaksouzian S., Klinger J. D., Woods D. E. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun. 1989 Mar;57(3):771–778. doi: 10.1128/iai.57.3.771-778.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. McKevitt A. I., Woods D. E. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol. 1984 Feb;19(2):291–293. doi: 10.1128/jcm.19.2.291-293.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. McLoughlin T. J., Quinn J. P., Bettermann A., Bookland R. Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling the disease. Appl Environ Microbiol. 1992 May;58(5):1760–1763. doi: 10.1128/aem.58.5.1760-1763.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Mecsas J., Rouviere P. E., Erickson J. W., Donohue T. J., Gross C. A. The activity of sigma E, an Escherichia coli heat-inducible sigma-factor, is modulated by expression of outer membrane proteins. Genes Dev. 1993 Dec;7(12B):2618–2628. doi: 10.1101/gad.7.12b.2618. [DOI] [PubMed] [Google Scholar]
  249. Medvedkin V. N., Permyakov E. A., Klimenko L. V., Mitin Y. V., Matsushima N., Nakayama S., Kretsinger R. H. Interactions of (Ala*Ala*Lys*Pro)n and (Lys*Lys*Ser*Pro)n with DNA. Proposed coiled-coil structure of AlgR3 and AlgP from Pseudomonas aeruginosa. Protein Eng. 1995 Jan;8(1):63–70. doi: 10.1093/protein/8.1.63. [DOI] [PubMed] [Google Scholar]
  250. Meluleni G. J., Grout M., Evans D. J., Pier G. B. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol. 1995 Aug 15;155(4):2029–2038. [PubMed] [Google Scholar]
  251. Meshulam T., Obedeanu N., Merzbach D., Sobel J. D. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa. Clin Immunol Immunopathol. 1984 Aug;32(2):151–165. doi: 10.1016/0090-1229(84)90117-x. [DOI] [PubMed] [Google Scholar]
  252. Meyer J. M., Hohnadel D., Hallé F. Cepabactin from Pseudomonas cepacia, a new type of siderophore. J Gen Microbiol. 1989 Jun;135(6):1479–1487. doi: 10.1099/00221287-135-6-1479. [DOI] [PubMed] [Google Scholar]
  253. Millar-Jones L., Paull A., Saunders Z., Goodchild M. C. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet. 1992 Aug 22;340(8817):491–491. doi: 10.1016/0140-6736(92)91817-r. [DOI] [PubMed] [Google Scholar]
  254. Min K. T., Hilditch C. M., Diederich B., Errington J., Yudkin M. D. Sigma F, the first compartment-specific transcription factor of B. subtilis, is regulated by an anti-sigma factor that is also a protein kinase. Cell. 1993 Aug 27;74(4):735–742. doi: 10.1016/0092-8674(93)90520-z. [DOI] [PubMed] [Google Scholar]
  255. Mohr C. D., Deretic V. Gene-scrambling mutagenesis: generation and analysis of insertional mutations in the alginate regulatory region of Pseudomonas aeruginosa. J Bacteriol. 1990 Nov;172(11):6252–6260. doi: 10.1128/jb.172.11.6252-6260.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Mohr C. D., Deretic V. In vitro interactions of the histone-like protein IHF with the algD promoter, a critical site for control of mucoidy in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1992 Dec 15;189(2):837–844. doi: 10.1016/0006-291x(92)92279-7. [DOI] [PubMed] [Google Scholar]
  257. Mohr C. D., Hibler N. S., Deretic V. AlgR, a response regulator controlling mucoidy in Pseudomonas aeruginosa, binds to the FUS sites of the algD promoter located unusually far upstream from the mRNA start site. J Bacteriol. 1991 Aug;173(16):5136–5143. doi: 10.1128/jb.173.16.5136-5143.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. Mohr C. D., Leveau J. H., Krieg D. P., Hibler N. S., Deretic V. AlgR-binding sites within the algD promoter make up a set of inverted repeats separated by a large intervening segment of DNA. J Bacteriol. 1992 Oct;174(20):6624–6633. doi: 10.1128/jb.174.20.6624-6633.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Mohr C. D., Martin D. W., Konyecsni W. M., Govan J. R., Lory S., Deretic V. Role of the far-upstream sites of the algD promoter and the algR and rpoN genes in environmental modulation of mucoidy in Pseudomonas aeruginosa. J Bacteriol. 1990 Nov;172(11):6576–6580. doi: 10.1128/jb.172.11.6576-6580.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Mohr C. D., Sonsteby S. K., Deretic V. The Pseudomonas aeruginosa homologs of hemC and hemD are linked to the gene encoding the regulator of mucoidy AlgR. Mol Gen Genet. 1994 Jan;242(2):177–184. doi: 10.1007/BF00391011. [DOI] [PubMed] [Google Scholar]
  261. Monday S. R., Schiller N. L. Alginate synthesis in Pseudomonas aeruginosa: the role of AlgL (alginate lyase) and AlgX. J Bacteriol. 1996 Feb;178(3):625–632. doi: 10.1128/jb.178.3.625-632.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Mork T., Hancock R. E. Mechanisms of nonopsonic phagocytosis of Pseudomonas aeruginosa. Infect Immun. 1993 Aug;61(8):3287–3293. doi: 10.1128/iai.61.8.3287-3293.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Mortensen J. E., Fisher M. C., LiPuma J. J. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol. 1995 Jan;16(1):30–32. doi: 10.1086/646999. [DOI] [PubMed] [Google Scholar]
  264. Mortensen J., Hansen A., Falk M., Nielsen I. K., Groth S. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest. 1993 Mar;103(3):805–811. doi: 10.1378/chest.103.3.805. [DOI] [PubMed] [Google Scholar]
  265. Nakamura Y., Hyodo S., Chonan E., Shigeta S., Yabuuchi E. Serological classification of Pseudomonas cepacia by somatic antigen. J Clin Microbiol. 1986 Jul;24(1):152–154. doi: 10.1128/jcm.24.1.152-154.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Nakazawa T., Yamada Y., Ishibashi M. Characterization of hemolysin in extracellular products of Pseudomonas cepacia. J Clin Microbiol. 1987 Feb;25(2):195–198. doi: 10.1128/jcm.25.2.195-198.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  267. Narbad A., Hewlins M. J., Gacesa P., Russell N. J. The use of 13C-n.m.r. spectroscopy to monitor alginate biosynthesis in mucoid Pseudomonas aeruginosa. Biochem J. 1990 May 1;267(3):579–584. doi: 10.1042/bj2670579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  268. Nelson J. W., Butler S. L., Brown P. H., Greening A. P., Govan J. R. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. J Med Microbiol. 1993 Jul;39(1):39–47. doi: 10.1099/00222615-39-1-39. [DOI] [PubMed] [Google Scholar]
  269. Nelson J. W., Butler S. L., Krieg D., Govan J. R. Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol. 1994 Feb;8(2):89–97. doi: 10.1111/j.1574-695X.1994.tb00430.x. [DOI] [PubMed] [Google Scholar]
  270. Nelson J. W., Doherty C. J., Brown P. H., Greening A. P., Kaufmann M. E., Govan J. R. Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet. 1991 Dec 14;338(8781):1525–1525. doi: 10.1016/0140-6736(91)92342-y. [DOI] [PubMed] [Google Scholar]
  271. Nelson J. W., Tredgett M. W., Sheehan J. K., Thornton D. J., Notman D., Govan J. R. Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis. Infect Immun. 1990 Jun;58(6):1489–1495. doi: 10.1128/iai.58.6.1489-1495.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Nichols W. W., Dorrington S. M., Slack M. P., Walmsley H. L. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob Agents Chemother. 1988 Apr;32(4):518–523. doi: 10.1128/aac.32.4.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Nickel J. C., Wright J. B., Ruseska I., Marrie T. J., Whitfield C., Costerton J. W. Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. Eur J Clin Microbiol. 1985 Apr;4(2):213–218. doi: 10.1007/BF02013600. [DOI] [PubMed] [Google Scholar]
  274. Norman D., Elborn J. S., Cordon S. M., Rayner R. J., Wiseman M. S., Hiller E. J., Shale D. J. Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax. 1991 Feb;46(2):91–95. doi: 10.1136/thx.46.2.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. O'Neil K. M., Herman J. H., Modlin J. F., Moxon E. R., Winkelstein J. A. Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr. 1986 Jun;108(6):940–942. doi: 10.1016/s0022-3476(86)80934-9. [DOI] [PubMed] [Google Scholar]
  276. Ohnishi K., Kutsukake K., Suzuki H., Lino T. A novel transcriptional regulation mechanism in the flagellar regulon of Salmonella typhimurium: an antisigma factor inhibits the activity of the flagellum-specific sigma factor, sigma F. Mol Microbiol. 1992 Nov;6(21):3149–3157. doi: 10.1111/j.1365-2958.1992.tb01771.x. [DOI] [PubMed] [Google Scholar]
  277. Oliver A. M., Weir D. M. Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate. J Clin Lab Immunol. 1983 Apr;10(4):221–224. [PubMed] [Google Scholar]
  278. Osman S. F., Fett W. F., Fishman M. L. Exopolysaccharides of the phytopathogen Pseudomonas syringae pv. glycinea. J Bacteriol. 1986 Apr;166(1):66–71. doi: 10.1128/jb.166.1.66-71.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  279. Otterlei M., Ostgaard K., Skjåk-Braek G., Smidsrød O., Soon-Shiong P., Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother (1991) 1991 Aug;10(4):286–291. doi: 10.1097/00002371-199108000-00007. [DOI] [PubMed] [Google Scholar]
  280. Otterlei M., Sundan A., Skjåk-Braek G., Ryan L., Smidsrød O., Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun. 1993 May;61(5):1917–1925. doi: 10.1128/iai.61.5.1917-1925.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  281. Ouchi K., Abe M., Karita M., Oguri T., Igari J., Nakazawa T. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing. J Clin Microbiol. 1995 Sep;33(9):2353–2357. doi: 10.1128/jcm.33.9.2353-2357.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  282. Page W. J., Sadoff H. L. Relationship between calcium and uroinic acids in the encystment of Azotobacter vinelandii. J Bacteriol. 1975 Apr;122(1):145–151. doi: 10.1128/jb.122.1.145-151.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  283. Parkinson J. S., Kofoid E. C. Communication modules in bacterial signaling proteins. Annu Rev Genet. 1992;26:71–112. doi: 10.1146/annurev.ge.26.120192.000443. [DOI] [PubMed] [Google Scholar]
  284. Parkinson J. S. Signal transduction schemes of bacteria. Cell. 1993 Jun 4;73(5):857–871. doi: 10.1016/0092-8674(93)90267-t. [DOI] [PubMed] [Google Scholar]
  285. Parr T. R., Jr, Moore R. A., Moore L. V., Hancock R. E. Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother. 1987 Jan;31(1):121–123. doi: 10.1128/aac.31.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  286. Pedersen S. S., Espersen F., Høiby N., Jensen T. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J Clin Microbiol. 1990 Apr;28(4):747–755. doi: 10.1128/jcm.28.4.747-755.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  287. Pedersen S. S., Espersen F., Høiby N., Shand G. H. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol. 1989 Apr;27(4):691–699. doi: 10.1128/jcm.27.4.691-699.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Pedersen S. S., Høiby N., Espersen F., Koch C. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax. 1992 Jan;47(1):6–13. doi: 10.1136/thx.47.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  289. Pedersen S. S., Jensen T., Pressler T., Høiby N., Rosendal K. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection? Acta Paediatr Scand. 1986 Sep;75(5):840–845. doi: 10.1111/j.1651-2227.1986.tb10299.x. [DOI] [PubMed] [Google Scholar]
  290. Pedersen S. S., Kharazmi A., Espersen F., Høiby N. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun. 1990 Oct;58(10):3363–3368. doi: 10.1128/iai.58.10.3363-3368.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Pedersen S. S. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl. 1992;28:1–79. [PubMed] [Google Scholar]
  292. Pegues D. A., Carson L. A., Tablan O. C., FitzSimmons S. C., Roman S. B., Miller J. M., Jarvis W. R. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr. 1994 May;124(5 Pt 1):694–702. doi: 10.1016/s0022-3476(05)81357-5. [DOI] [PubMed] [Google Scholar]
  293. Pfeffer K. D., Huecksteadt T. P., Hoidal J. R. Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am J Respir Cell Mol Biol. 1993 Nov;9(5):511–519. doi: 10.1165/ajrcmb/9.5.511. [DOI] [PubMed] [Google Scholar]
  294. Phillis J. W., Smith-Barbour M., O'Regan M. H., Perkins L. M. Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochem Res. 1994 Sep;19(9):1125–1130. doi: 10.1007/BF00965145. [DOI] [PubMed] [Google Scholar]
  295. Pier G. B., DesJardin D., Grout M., Garner C., Bennett S. E., Pekoe G., Fuller S. A., Thornton M. O., Harkonen W. S., Miller H. C. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infect Immun. 1994 Sep;62(9):3972–3979. doi: 10.1128/iai.62.9.3972-3979.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. Pier G. B., Desjardins D., Aguilar T., Barnard M., Speert D. P. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients. J Clin Microbiol. 1986 Aug;24(2):189–196. doi: 10.1128/jcm.24.2.189-196.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  297. Pier G. B., Elcock M. E. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. J Immunol. 1984 Aug;133(2):734–739. [PubMed] [Google Scholar]
  298. Pier G. B., Grout M., Desjardins D. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins. J Immunol. 1991 Sep 15;147(6):1869–1876. [PubMed] [Google Scholar]
  299. Pier G. B., Grout M., Zaidi T. S., Olsen J. C., Johnson L. G., Yankaskas J. R., Goldberg J. B. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science. 1996 Jan 5;271(5245):64–67. doi: 10.1126/science.271.5245.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  300. Pier G. B., Meluleni G., Neuger E. A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect Immun. 1992 Nov;60(11):4768–4776. doi: 10.1128/iai.60.11.4768-4776.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Pier G. B., Saunders J. M., Ames P., Edwards M. S., Auerbach H., Goldfarb J., Speert D. P., Hurwitch S. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med. 1987 Sep 24;317(13):793–798. doi: 10.1056/NEJM198709243171303. [DOI] [PubMed] [Google Scholar]
  302. Pier G. B., Small G. J., Warren H. B. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science. 1990 Aug 3;249(4968):537–540. doi: 10.1126/science.2116663. [DOI] [PubMed] [Google Scholar]
  303. Pier G. B., Takeda S., Grout M., Markham R. B. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. J Clin Invest. 1993 Mar;91(3):1079–1087. doi: 10.1172/JCI116265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  304. Pier G. B. Vaccine potential of Pseudomonas aeruginosa mucoid exopolysaccharide (alginate). Antibiot Chemother (1971) 1991;44:136–142. doi: 10.1159/000420308. [DOI] [PubMed] [Google Scholar]
  305. Pindar D. F., Bucke C. The biosynthesis of alginic acid by Azotobacter vinelandii. Biochem J. 1975 Dec;152(3):617–622. doi: 10.1042/bj1520617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  306. Pitt T. L., Kaufmann M. E., Patel P. S., Benge L. C., Gaskin S., Livermore D. M. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol. 1996 Mar;44(3):203–210. doi: 10.1099/00222615-44-3-203. [DOI] [PubMed] [Google Scholar]
  307. Poole K., Krebes K., McNally C., Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol. 1993 Nov;175(22):7363–7372. doi: 10.1128/jb.175.22.7363-7372.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  308. Prince A. Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract. Microb Pathog. 1992 Oct;13(4):251–260. doi: 10.1016/0882-4010(92)90035-m. [DOI] [PubMed] [Google Scholar]
  309. Prince A. Antibiotic resistance of Pseudomonas species. J Pediatr. 1986 May;108(5 Pt 2):830–834. doi: 10.1016/s0022-3476(86)80753-3. [DOI] [PubMed] [Google Scholar]
  310. Proenca R., Niu W. W., Cacalano G., Prince A. The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases. Antimicrob Agents Chemother. 1993 Apr;37(4):667–674. doi: 10.1128/aac.37.4.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  311. Pugashetti B. K., Metzger H. M., Jr, Vadas L., Feingold D. S. Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains. J Clin Microbiol. 1982 Oct;16(4):686–691. doi: 10.1128/jcm.16.4.686-691.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  312. Pugashetti B. K., Vadas L., Prihar H. S., Feingold D. S. GDPmannose dehydrogenase and biosynthesis of alginate-like polysaccharide in a mucoid strain of Pseudomonas aeruginosa. J Bacteriol. 1983 Feb;153(2):1107–1110. doi: 10.1128/jb.153.2.1107-1110.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  313. Pujol M., Corbella X., Carratala J., Gudiol F. Community-acquired bacteremic Pseudomonas cepacia pneumonia in an immunocompetent host. Clin Infect Dis. 1992 Nov;15(5):887–888. doi: 10.1093/clind/15.5.887. [DOI] [PubMed] [Google Scholar]
  314. Raina S., Missiakas D., Georgopoulos C. The rpoE gene encoding the sigma E (sigma 24) heat shock sigma factor of Escherichia coli. EMBO J. 1995 Mar 1;14(5):1043–1055. doi: 10.1002/j.1460-2075.1995.tb07085.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Ramphal R., Guay C., Pier G. B. Pseudomonas aeruginosa adhesins for tracheobronchial mucin. Infect Immun. 1987 Mar;55(3):600–603. doi: 10.1128/iai.55.3.600-603.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  316. Ramphal R., Pier G. B. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Infect Immun. 1985 Jan;47(1):1–4. doi: 10.1128/iai.47.1.1-4.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  317. Ratnaningsih E., Dharmsthiti S., Krishnapillai V., Morgan A., Sinclair M., Holloway B. W. A combined physical and genetic map of Pseudomonas aeruginosa PAO. J Gen Microbiol. 1990 Dec;136(12):2351–2357. doi: 10.1099/00221287-136-12-2351. [DOI] [PubMed] [Google Scholar]
  318. Rehm B. H., Boheim G., Tommassen J., Winkler U. K. Overexpression of algE in Escherichia coli: subcellular localization, purification, and ion channel properties. J Bacteriol. 1994 Sep;176(18):5639–5647. doi: 10.1128/jb.176.18.5639-5647.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  319. Reynolds H. Y., Di Sant'Agnese P. A., Zierdt C. H. Mucoid Pseudomonas aeruginosa. A sign of cystic fibrosis in young adults with chronic pulmonary disease? JAMA. 1976 Nov 8;236(19):2190–2192. doi: 10.1001/jama.236.19.2190. [DOI] [PubMed] [Google Scholar]
  320. Richman-Eisenstat J. B., Jorens P. G., Hébert C. A., Ueki I., Nadel J. A. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol. 1993 Apr;264(4 Pt 1):L413–L418. doi: 10.1152/ajplung.1993.264.4.L413. [DOI] [PubMed] [Google Scholar]
  321. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  322. Rodley P. D., Römling U., Tümmler B. A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol. 1995 Jul;17(1):57–67. doi: 10.1111/j.1365-2958.1995.mmi_17010057.x. [DOI] [PubMed] [Google Scholar]
  323. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  324. Roop R. M., 2nd, Fletcher T. W., Sriranganathan N. M., Boyle S. M., Schurig G. G. Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun. 1994 Mar;62(3):1000–1007. doi: 10.1128/iai.62.3.1000-1007.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  325. Rosenstein B. J., Hall D. E. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. Johns Hopkins Med J. 1980 Nov;147(5):188–189. [PubMed] [Google Scholar]
  326. Rouvière P. E., De Las Peñas A., Mecsas J., Lu C. Z., Rudd K. E., Gross C. A. rpoE, the gene encoding the second heat-shock sigma factor, sigma E, in Escherichia coli. EMBO J. 1995 Mar 1;14(5):1032–1042. doi: 10.1002/j.1460-2075.1995.tb07084.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  327. Roychoudhury S., May T. B., Gill J. F., Singh S. K., Feingold D. S., Chakrabarty A. M. Purification and characterization of guanosine diphospho-D-mannose dehydrogenase. A key enzyme in the biosynthesis of alginate by Pseudomonas aeruginosa. J Biol Chem. 1989 Jun 5;264(16):9380–9385. [PubMed] [Google Scholar]
  328. Roychoudhury S., Sakai K., Chakrabarty A. M. AlgR2 is an ATP/GTP-dependent protein kinase involved in alginate synthesis by Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2659–2663. doi: 10.1073/pnas.89.7.2659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  329. Roychoudhury S., Sakai K., Schlictman D., Chakrabarty A. M. Signal transduction in exopolysaccharide alginate synthesis: phosphorylation of the response regulator AlgR1 in Pseudomonas aeruginosa and Escherichia coli. Gene. 1992 Mar 1;112(1):45–51. doi: 10.1016/0378-1119(92)90301-5. [DOI] [PubMed] [Google Scholar]
  330. Roychoudhury S., Zielinski N. A., Ninfa A. J., Allen N. E., Jungheim L. N., Nicas T. I., Chakrabarty A. M. Inhibitors of two-component signal transduction systems: inhibition of alginate gene activation in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):965–969. doi: 10.1073/pnas.90.3.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  331. Russell N. J., Gacesa P. Chemistry and biology of the alginate of mucoid strains of Pseudomonas aeruginosa in cystic fibrosis. Mol Aspects Med. 1988;10(1):1–91. doi: 10.1016/0098-2997(88)90002-7. [DOI] [PubMed] [Google Scholar]
  332. Römling U., Fiedler B., Bosshammer J., Grothues D., Greipel J., von der Hardt H., Tümmler B. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis. 1994 Dec;170(6):1616–1621. doi: 10.1093/infdis/170.6.1616. [DOI] [PubMed] [Google Scholar]
  333. Römling U., Wingender J., Müller H., Tümmler B. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol. 1994 Jun;60(6):1734–1738. doi: 10.1128/aem.60.6.1734-1738.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  334. Sadoff H. L. Encystment and germination in Azotobacter vinelandii. Bacteriol Rev. 1975 Dec;39(4):516–539. doi: 10.1128/br.39.4.516-539.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  335. Saiman L., Cacalano G., Prince A. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun. 1990 Aug;58(8):2578–2584. doi: 10.1128/iai.58.8.2578-2584.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  336. Saiman L., Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest. 1993 Oct;92(4):1875–1880. doi: 10.1172/JCI116779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  337. Saiman L., Sadoff J., Prince A. Cross-reactivity of Pseudomonas aeruginosa antipilin monoclonal antibodies with heterogeneous strains of P. aeruginosa and Pseudomonas cepacia. Infect Immun. 1989 Sep;57(9):2764–2770. doi: 10.1128/iai.57.9.2764-2770.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  338. Sajjan S. U., Forstner J. F. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun. 1992 Apr;60(4):1434–1440. doi: 10.1128/iai.60.4.1434-1440.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  339. Sajjan U. S., Corey M., Karmali M. A., Forstner J. F. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):648–656. doi: 10.1172/JCI115631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  340. Sajjan U. S., Sun L., Goldstein R., Forstner J. F. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol. 1995 Feb;177(4):1030–1038. doi: 10.1128/jb.177.4.1030-1038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  341. Schiller N. L., Hatch R. A., Joiner K. A. Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect Immun. 1989 Jun;57(6):1707–1713. doi: 10.1128/iai.57.6.1707-1713.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  342. Schiller N. L., Monday S. R., Boyd C. M., Keen N. T., Ohman D. E. Characterization of the Pseudomonas aeruginosa alginate lyase gene (algL): cloning, sequencing, and expression in Escherichia coli. J Bacteriol. 1993 Aug;175(15):4780–4789. doi: 10.1128/jb.175.15.4780-4789.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  343. Schlictman D., Kavanaugh-Black A., Shankar S., Chakrabarty A. M. Energy metabolism and alginate biosynthesis in Pseudomonas aeruginosa: role of the tricarboxylic acid cycle. J Bacteriol. 1994 Oct;176(19):6023–6029. doi: 10.1128/jb.176.19.6023-6029.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  344. Schlictman D., Kubo M., Shankar S., Chakrabarty A. M. Regulation of nucleoside diphosphate kinase and secretable virulence factors in Pseudomonas aeruginosa: roles of algR2 and algH. J Bacteriol. 1995 May;177(9):2469–2474. doi: 10.1128/jb.177.9.2469-2474.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  345. Schurr M. J., Martin D. W., Mudd M. H., Deretic V. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy. J Bacteriol. 1994 Jun;176(11):3375–3382. doi: 10.1128/jb.176.11.3375-3382.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  346. Schurr M. J., Martin D. W., Mudd M. H., Hibler N. S., Boucher J. C., Deretic V. The algD promoter: regulation of alginate production by Pseudomonas aeruginosa in cystic fibrosis. Cell Mol Biol Res. 1993;39(4):371–376. [PubMed] [Google Scholar]
  347. Schurr M. J., Yu H., Boucher J. C., Hibler N. S., Deretic V. Multiple promoters and induction by heat shock of the gene encoding the alternative sigma factor AlgU (sigma E) which controls mucoidy in cystic fibrosis isolates of Pseudomonas aeruginosa. J Bacteriol. 1995 Oct;177(19):5670–5679. doi: 10.1128/jb.177.19.5670-5679.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  348. Schurr M. J., Yu H., Martinez-Salazar J. M., Boucher J. C., Deretic V. Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis. J Bacteriol. 1996 Aug;178(16):4997–5004. doi: 10.1128/jb.178.16.4997-5004.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  349. Schurr M. J., Yu H., Martinez-Salazar J. M., Hibler N. S., Deretic V. Biochemical characterization and posttranslational modification of AlgU, a regulator of stress response in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1995 Nov 22;216(3):874–880. doi: 10.1006/bbrc.1995.2703. [DOI] [PubMed] [Google Scholar]
  350. Schwarzmann S., Boring J. R. Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa. Infect Immun. 1971 Jun;3(6):762–767. doi: 10.1128/iai.3.6.762-767.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  351. Schweizer H. P., Po C., Bacic M. K. Identification of Pseudomonas aeruginosa glpM, whose gene product is required for efficient alginate biosynthesis from various carbon sources. J Bacteriol. 1995 Aug;177(16):4801–4804. doi: 10.1128/jb.177.16.4801-4804.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  352. Scordilis G. E., Ree H., Lessie T. G. Identification of transposable elements which activate gene expression in Pseudomonas cepacia. J Bacteriol. 1987 Jan;169(1):8–13. doi: 10.1128/jb.169.1.8-13.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  353. Shaw D., Poxton I. R., Govan J. R. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol. 1995 Apr;11(2):99–106. doi: 10.1111/j.1574-695X.1995.tb00095.x. [DOI] [PubMed] [Google Scholar]
  354. Shields M. S., Reagin M. J. Selection of a Pseudomonas cepacia strain constitutive for the degradation of trichloroethylene. Appl Environ Microbiol. 1992 Dec;58(12):3977–3983. doi: 10.1128/aem.58.12.3977-3983.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  355. Shinabarger D., Berry A., May T. B., Rothmel R., Fialho A., Chakrabarty A. M. Purification and characterization of phosphomannose isomerase-guanosine diphospho-D-mannose pyrophosphorylase. A bifunctional enzyme in the alginate biosynthetic pathway of Pseudomonas aeruginosa. J Biol Chem. 1991 Feb 5;266(4):2080–2088. [PubMed] [Google Scholar]
  356. Shinabarger D., May T. B., Boyd A., Ghosh M., Chakrabarty A. M. Nucleotide sequence and expression of the Pseudomonas aeruginosa algF gene controlling acetylation of alginate. Mol Microbiol. 1993 Sep;9(5):1027–1035. doi: 10.1111/j.1365-2958.1993.tb01232.x. [DOI] [PubMed] [Google Scholar]
  357. Simpson D. A., Ramphal R., Lory S. Genetic analysis of Pseudomonas aeruginosa adherence: distinct genetic loci control attachment to epithelial cells and mucins. Infect Immun. 1992 Sep;60(9):3771–3779. doi: 10.1128/iai.60.9.3771-3779.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  358. Simpson I. N., Finlay J., Winstanley D. J., Dewhurst N., Nelson J. W., Butler S. L., Govan J. R. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother. 1994 Sep;34(3):353–361. doi: 10.1093/jac/34.3.353. [DOI] [PubMed] [Google Scholar]
  359. Simpson I. N., Hunter R., Govan J. R., Nelson J. W. Do all Pseudomonas cepacia produce carbapenemases? J Antimicrob Chemother. 1993 Aug;32(2):339–341. doi: 10.1093/jac/32.2.339-a. [DOI] [PubMed] [Google Scholar]
  360. Simpson J. A., Smith S. E., Dean R. T. Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. J Gen Microbiol. 1988 Jan;134(1):29–36. doi: 10.1099/00221287-134-1-29. [DOI] [PubMed] [Google Scholar]
  361. Simpson J. A., Smith S. E., Dean R. T. Alginate may accumulate in cystic fibrosis lung because the enzymatic and free radical capacities of phagocytic cells are inadequate for its degradation. Biochem Mol Biol Int. 1993 Aug;30(6):1021–1034. [PubMed] [Google Scholar]
  362. Simpson J. A., Smith S. E., Dean R. T. Scavenging by alginate of free radicals released by macrophages. Free Radic Biol Med. 1989;6(4):347–353. doi: 10.1016/0891-5849(89)90078-6. [DOI] [PubMed] [Google Scholar]
  363. Smith D. L., Smith E. G., Gumery L. B., Stableforth D. E. Pseudomonas cepacia infection in cystic fibrosis. Lancet. 1992 Jan 25;339(8787):252–252. doi: 10.1016/0140-6736(92)90063-9. [DOI] [PubMed] [Google Scholar]
  364. Smith J. J., Travis S. M., Greenberg E. P., Welsh M. J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996 Apr 19;85(2):229–236. doi: 10.1016/s0092-8674(00)81099-5. [DOI] [PubMed] [Google Scholar]
  365. Smith S. N., Steel D. M., Middleton P. G., Munkonge F. M., Geddes D. M., Caplen N. J., Porteous D. J., Dorin J. R., Alton E. W. Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans. Am J Physiol. 1995 Feb;268(2 Pt 1):C297–C307. doi: 10.1152/ajpcell.1995.268.2.C297. [DOI] [PubMed] [Google Scholar]
  366. Snouwaert J. N., Brigman K. K., Latour A. M., Malouf N. N., Boucher R. C., Smithies O., Koller B. H. An animal model for cystic fibrosis made by gene targeting. Science. 1992 Aug 21;257(5073):1083–1088. doi: 10.1126/science.257.5073.1083. [DOI] [PubMed] [Google Scholar]
  367. Sokol P. A., Lewis C. J., Dennis J. J. Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol. 1992 Mar;36(3):184–189. doi: 10.1099/00222615-36-3-184. [DOI] [PubMed] [Google Scholar]
  368. Sokol P. A., Luan M. Z., Storey D. G., Thirukkumaran P. Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements. J Bacteriol. 1994 Feb;176(3):553–562. doi: 10.1128/jb.176.3.553-562.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  369. Sokol P. A. Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia. J Clin Microbiol. 1986 Mar;23(3):560–562. doi: 10.1128/jcm.23.3.560-562.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  370. Sokol P. A., Woods D. E. Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb Pathog. 1988 Sep;5(3):197–205. doi: 10.1016/0882-4010(88)90022-8. [DOI] [PubMed] [Google Scholar]
  371. Soon-Shiong P., Feldman E., Nelson R., Heintz R., Yao Q., Yao Z., Zheng T., Merideth N., Skjak-Braek G., Espevik T. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5843–5847. doi: 10.1073/pnas.90.12.5843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  372. Speert D. P., Bond M., Woodman R. C., Curnutte J. T. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis. 1994 Dec;170(6):1524–1531. doi: 10.1093/infdis/170.6.1524. [DOI] [PubMed] [Google Scholar]
  373. Speert D. P., Campbell M. E., Davidson A. G., Wong L. T. Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis. J Infect Dis. 1993 Jan;167(1):226–229. doi: 10.1093/infdis/167.1.226. [DOI] [PubMed] [Google Scholar]
  374. Speert D. P., Dimmick J. E., Pier G. B., Saunders J. M., Hancock R. E., Kelly N. An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis. Pediatr Res. 1987 Dec;22(6):743–747. doi: 10.1203/00006450-198712000-00026. [DOI] [PubMed] [Google Scholar]
  375. Speert D. P., Farmer S. W., Campbell M. E., Musser J. M., Selander R. K., Kuo S. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis. J Clin Microbiol. 1990 Feb;28(2):188–194. doi: 10.1128/jcm.28.2.188-194.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  376. Speert D. P., Gordon S. Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose. J Clin Invest. 1992 Sep;90(3):1085–1092. doi: 10.1172/JCI115924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  377. Speert D. P., Loh B. A., Cabral D. A., Salit I. E. Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity. Infect Immun. 1986 Jul;53(1):207–212. doi: 10.1128/iai.53.1.207-212.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  378. Stableforth D. E., Smith D. L. Pseudomonas cepacia in cystic fibrosis. Thorax. 1994 Jul;49(7):629–630. doi: 10.1136/thx.49.7.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  379. Staugas R. E., Harvey D. P., Ferrante A., Nandoskar M., Allison A. C. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes. Infect Immun. 1992 Aug;60(8):3162–3168. doi: 10.1128/iai.60.8.3162-3168.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  380. Steinbach S., Sun L., Jiang R. Z., Flume P., Gilligan P., Egan T. M., Goldstein R. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994 Oct 13;331(15):981–987. doi: 10.1056/NEJM199410133311504. [DOI] [PubMed] [Google Scholar]
  381. Stiver H. G., Zachidniak K., Speert D. P. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa. Clin Invest Med. 1988 Aug;11(4):247–252. [PubMed] [Google Scholar]
  382. Stock J. B., Ninfa A. J., Stock A. M. Protein phosphorylation and regulation of adaptive responses in bacteria. Microbiol Rev. 1989 Dec;53(4):450–490. doi: 10.1128/mr.53.4.450-490.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  383. Stover G. B., Drake D. R., Montie T. C. Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia. Infect Immun. 1983 Sep;41(3):1099–1104. doi: 10.1128/iai.41.3.1099-1104.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  384. Strauch K. L., Beckwith J. An Escherichia coli mutation preventing degradation of abnormal periplasmic proteins. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1576–1580. doi: 10.1073/pnas.85.5.1576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  385. Straus D. C., Lonon M. K., Hutson J. C. Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase. J Med Microbiol. 1992 Nov;37(5):335–340. doi: 10.1099/00222615-37-5-335. [DOI] [PubMed] [Google Scholar]
  386. Straus D. C., Lonon M. K., Woods D. E., Garner C. W. Production of an extracellular toxic complex by various strains of Pseudomonas cepacia. J Med Microbiol. 1989 Sep;30(1):17–22. doi: 10.1099/00222615-30-1-17. [DOI] [PubMed] [Google Scholar]
  387. Stull T. L., LiPuma J. J., Edlind T. D. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Dis. 1988 Feb;157(2):280–286. doi: 10.1093/infdis/157.2.280. [DOI] [PubMed] [Google Scholar]
  388. Stutman H. R., Marks M. I. Pulmonary infections in children with cystic fibrosis. Semin Respir Infect. 1987 Sep;2(3):166–176. [PubMed] [Google Scholar]
  389. Su C. J., da Cunha A., Wernette C. M., Reusch R. N., Sadoff H. L. Protein synthesis during encystment of Azotobacter vinelandii. J Bacteriol. 1987 Oct;169(10):4451–4456. doi: 10.1128/jb.169.10.4451-4456.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  390. Sun L., Jiang R. Z., Steinbach S., Holmes A., Campanelli C., Forstner J., Sajjan U., Tan Y., Riley M., Goldstein R. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995 Jul;1(7):661–666. doi: 10.1038/nm0795-661. [DOI] [PubMed] [Google Scholar]
  391. Suter S., Schaad U. B., Roux-Lombard P., Girardin E., Grau G., Dayer J. M. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis. 1989 Dec;140(6):1640–1644. doi: 10.1164/ajrccm/140.6.1640. [DOI] [PubMed] [Google Scholar]
  392. Tablan O. C., Carson L. A., Cusick L. B., Bland L. A., Martone W. J., Jarvis W. R. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol. 1987 Mar;25(3):485–487. doi: 10.1128/jcm.25.3.485-487.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  393. Tablan O. C., Chorba T. L., Schidlow D. V., White J. W., Hardy K. A., Gilligan P. H., Morgan W. M., Carson L. A., Martone W. J., Jason J. M. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985 Sep;107(3):382–387. doi: 10.1016/s0022-3476(85)80511-4. [DOI] [PubMed] [Google Scholar]
  394. Takigawa K., Fujita J., Negayama K., Yamagishi Y., Yamaji Y., Ouchi K., Yamada K., Abe M., Nakazawa T., Kawanishi K. Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with contaminated nebulizer devices. Kansenshogaku Zasshi. 1993 Nov;67(11):1115–1125. doi: 10.11150/kansenshogakuzasshi1970.67.1115. [DOI] [PubMed] [Google Scholar]
  395. Taplin D., Bassett D. C., Mertz P. M. Foot lesions associated with Pseudomonas cepacia. Lancet. 1971 Sep 11;2(7724):568–571. doi: 10.1016/s0140-6736(71)92150-7. [DOI] [PubMed] [Google Scholar]
  396. Tatnell P. J., Russell N. J., Gacesa P. A metabolic study of the activity of GDP-mannose dehydrogenase and concentrations of activated intermediates of alginate biosynthesis in Pseudomonas aeruginosa. J Gen Microbiol. 1993 Jan;139(1):119–127. doi: 10.1099/00221287-139-1-119. [DOI] [PubMed] [Google Scholar]
  397. Tatnell P. J., Russell N. J., Gacesa P. Chemical analysis of alginates from mucoid strains of Pseudomonas aeruginosa. Biochem Soc Trans. 1994 Aug;22(3):310S–310S. doi: 10.1042/bst022310s. [DOI] [PubMed] [Google Scholar]
  398. Tatum F. M., Cheville N. F., Morfitt D. Cloning, characterization and construction of htrA and htrA-like mutants of Brucella abortus and their survival in BALB/c mice. Microb Pathog. 1994 Jul;17(1):23–36. doi: 10.1006/mpat.1994.1049. [DOI] [PubMed] [Google Scholar]
  399. Terry J. M., Piña S. E., Mattingly S. J. Environmental conditions which influence mucoid conversion Pseudomonas aeruginosa PAO1. Infect Immun. 1991 Feb;59(2):471–477. doi: 10.1128/iai.59.2.471-477.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  400. Thomassen M. J., Demko C. A., Boxerbaum B., Stern R. C., Kuchenbrod P. J. Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. J Infect Dis. 1979 Dec;140(6):873–880. doi: 10.1093/infdis/140.6.873. [DOI] [PubMed] [Google Scholar]
  401. Thomassen M. J., Demko C. A., Doershuk C. F., Stern R. C., Klinger J. D. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis. 1986 Oct;134(4):669–671. doi: 10.1164/arrd.1986.134.4.669. [DOI] [PubMed] [Google Scholar]
  402. Thomassen M. J., Demko C. A., Klinger J. D., Stern R. C. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis. 1985 May;131(5):791–796. doi: 10.1164/arrd.1985.131.5.791. [DOI] [PubMed] [Google Scholar]
  403. Totten P. A., Lara J. C., Lory S. The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene. J Bacteriol. 1990 Jan;172(1):389–396. doi: 10.1128/jb.172.1.389-396.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  404. Toussaint B., Delic-Attree I., Vignais P. M. Pseudomonas aeruginosa contains an IHF-like protein that binds to the algD promoter. Biochem Biophys Res Commun. 1993 Oct 15;196(1):416–421. doi: 10.1006/bbrc.1993.2265. [DOI] [PubMed] [Google Scholar]
  405. Tredgett M. W., Doherty C., Govan J. R. Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases. J Med Microbiol. 1990 Jul;32(3):169–172. doi: 10.1099/00222615-32-3-169. [DOI] [PubMed] [Google Scholar]
  406. Valerius N. H., Koch C., Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991 Sep 21;338(8769):725–726. doi: 10.1016/0140-6736(91)91446-2. [DOI] [PubMed] [Google Scholar]
  407. Vasil M. L., Chamberlain C., Grant C. C. Molecular studies of Pseudomonas exotoxin A gene. Infect Immun. 1986 May;52(2):538–548. doi: 10.1128/iai.52.2.538-548.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  408. Vasil M. L., Krieg D. P., Kuhns J. S., Ogle J. W., Shortridge V. D., Ostroff R. M., Vasil A. I. Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect Immun. 1990 Dec;58(12):4020–4029. doi: 10.1128/iai.58.12.4020-4029.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  409. Venturi V., Otten M., Korse V., Brouwer B., Leong J., Weisbeek P. Alginate regulatory and biosynthetic gene homologs in Pseudomonas putida WCS358: correlation with the siderophore regulatory gene pfrA. Gene. 1995 Mar 21;155(1):83–88. doi: 10.1016/0378-1119(94)00868-s. [DOI] [PubMed] [Google Scholar]
  410. Venturi V., Ottevanger C., Leong J., Weisbeek P. J. Identification and characterization of a siderophore regulatory gene (pfrA) of Pseudomonas putida WCS358: homology to the alginate regulatory gene algQ of Pseudomonas aeruginosa. Mol Microbiol. 1993 Oct;10(1):63–73. doi: 10.1111/j.1365-2958.1993.tb00904.x. [DOI] [PubMed] [Google Scholar]
  411. Venturi V., Weisbeek P., Koster M. Gene regulation of siderophore-mediated iron acquisition in Pseudomonas: not only the Fur repressor. Mol Microbiol. 1995 Aug;17(4):603–610. doi: 10.1111/j.1365-2958.1995.mmi_17040603.x. [DOI] [PubMed] [Google Scholar]
  412. Vishwanath S., Ramphal R., Guay C. M., DesJardins D., Pier G. B. Respiratory-mucin inhibition of the opsonophagocytic killing of Pseudomonas aeruginosa. Infect Immun. 1988 Sep;56(9):2218–2222. doi: 10.1128/iai.56.9.2218-2222.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  413. Wainwright B. The molecular pathology of cystic fibrosis. Curr Biol. 1991 Apr;1(2):80–82. doi: 10.1016/0960-9822(91)90283-3. [DOI] [PubMed] [Google Scholar]
  414. Walters S., Smith E. G. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications. Lancet. 1993 Jul 3;342(8862):3–4. [PubMed] [Google Scholar]
  415. Wang Q. P., Kaguni J. M. A novel sigma factor is involved in expression of the rpoH gene of Escherichia coli. J Bacteriol. 1989 Aug;171(8):4248–4253. doi: 10.1128/jb.171.8.4248-4253.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  416. Wang S. K., Sa'-Correia I., Darzins A., Chakrabarty A. M. Characterization of the Pseudomonas aeruginosa alginate (alg) gene region II. J Gen Microbiol. 1987 Aug;133(8):2303–2314. doi: 10.1099/00221287-133-8-2303. [DOI] [PubMed] [Google Scholar]
  417. Warner J. O. Immunology of cystic fibrosis. Br Med Bull. 1992 Oct;48(4):893–911. doi: 10.1093/oxfordjournals.bmb.a072584. [DOI] [PubMed] [Google Scholar]
  418. Wheeler W. B., Williams M., Matthews W. J., Jr, Colten H. R. Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr. 1984 May;104(5):695–699. doi: 10.1016/s0022-3476(84)80946-4. [DOI] [PubMed] [Google Scholar]
  419. Wilson R., Roberts D., Cole P. Effect of bacterial products on human ciliary function in vitro. Thorax. 1985 Feb;40(2):125–131. doi: 10.1136/thx.40.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  420. Wise M. G., Shimkets L. J., McArthur J. V. Genetic structure of a lotic population of Burkolderia (Pseudomonas) cepacia. Appl Environ Microbiol. 1995 May;61(5):1791–1798. doi: 10.1128/aem.61.5.1791-1798.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  421. Woods D. E., Bass J. A., Johanson W. G., Jr, Straus D. C. Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun. 1980 Dec;30(3):694–699. doi: 10.1128/iai.30.3.694-699.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  422. Woods D. E., Sokol P. A., Bryan L. E., Storey D. G., Mattingly S. J., Vogel H. J., Ceri H. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. J Infect Dis. 1991 Jan;163(1):143–149. doi: 10.1093/infdis/163.1.143. [DOI] [PubMed] [Google Scholar]
  423. Woods D. E., Straus D. C., Johanson W. G., Jr, Berry V. K., Bass J. A. Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun. 1980 Sep;29(3):1146–1151. doi: 10.1128/iai.29.3.1146-1151.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  424. Wozniak D. J. Integration host factor and sequences downstream of the Pseudomonas aeruginosa algD transcription start site are required for expression. J Bacteriol. 1994 Aug;176(16):5068–5076. doi: 10.1128/jb.176.16.5068-5076.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  425. Wozniak D. J., Ohman D. E. Pseudomonas aeruginosa AlgB, a two-component response regulator of the NtrC family, is required for algD transcription. J Bacteriol. 1991 Feb;173(4):1406–1413. doi: 10.1128/jb.173.4.1406-1413.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  426. Wozniak D. J., Ohman D. E. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT. J Bacteriol. 1994 Oct;176(19):6007–6014. doi: 10.1128/jb.176.19.6007-6014.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  427. Yabuuchi E., Kosako Y., Oyaizu H., Yano I., Hotta H., Hashimoto Y., Ezaki T., Arakawa M. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol. 1992;36(12):1251–1275. doi: 10.1111/j.1348-0421.1992.tb02129.x. [DOI] [PubMed] [Google Scholar]
  428. Ye R. W., Zielinski N. A., Chakrabarty A. M. Purification and characterization of phosphomannomutase/phosphoglucomutase from Pseudomonas aeruginosa involved in biosynthesis of both alginate and lipopolysaccharide. J Bacteriol. 1994 Aug;176(16):4851–4857. doi: 10.1128/jb.176.16.4851-4857.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  429. Yoshimura K., Nakamura H., Trapnell B. C., Chu C. S., Dalemans W., Pavirani A., Lecocq J. P., Crystal R. G. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res. 1991 Oct 11;19(19):5417–5423. doi: 10.1093/nar/19.19.5417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  430. Yu H., Boucher J. C., Hibler N. S., Deretic V. Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE). Infect Immun. 1996 Jul;64(7):2774–2781. doi: 10.1128/iai.64.7.2774-2781.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  431. Yu H., Schurr M. J., Deretic V. Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU: E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa. J Bacteriol. 1995 Jun;177(11):3259–3268. doi: 10.1128/jb.177.11.3259-3268.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  432. Zar H., Saiman L., Quittell L., Prince A. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J Pediatr. 1995 Feb;126(2):230–233. doi: 10.1016/s0022-3476(95)70549-x. [DOI] [PubMed] [Google Scholar]
  433. Zhou L., Dey C. R., Wert S. E., DuVall M. D., Frizzell R. A., Whitsett J. A. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. 1994 Dec 9;266(5191):1705–1708. doi: 10.1126/science.7527588. [DOI] [PubMed] [Google Scholar]
  434. Zielinski N. A., Chakrabarty A. M., Berry A. Characterization and regulation of the Pseudomonas aeruginosa algC gene encoding phosphomannomutase. J Biol Chem. 1991 May 25;266(15):9754–9763. [PubMed] [Google Scholar]
  435. Zielinski N. A., Maharaj R., Roychoudhury S., Danganan C. E., Hendrickson W., Chakrabarty A. M. Alginate synthesis in Pseudomonas aeruginosa: environmental regulation of the algC promoter. J Bacteriol. 1992 Dec;174(23):7680–7688. doi: 10.1128/jb.174.23.7680-7688.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  436. al-Awqati Q., Barasch J., Landry D. Chloride channels of intracellular organelles and their potential role in cystic fibrosis. J Exp Biol. 1992 Nov;172:245–266. doi: 10.1242/jeb.172.1.245. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES